Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Directors’ report and consolidated financial statements
Kirkwood Hospice
Trustees’ report and financial statements Company registered number 01645888 Charity registration number 512987
For the year ended 31 March 2026
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Contents | |
|---|---|
| Trustees' Report | 2 |
| Statement of Trustees' Responsibilites | 30 |
| Independent Auditor's Report to the Members of Kirkwood Hospice | 31 |
| Consolidated Statement of Financial Actvites | 35 |
| Balance Sheets | 36 |
| Consolidated Cash Flow Statement | 37 |
| Notes to the Financial Statements | 38 |
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026
Welcome & Foreword from the Chief Executive and Chair
The previous two years have been among the most significant in The Kirkwood's history.
During 2024–25, we took some of the most difficult decisions our charity has ever faced. Those decisions affected patients and families, employees and volunteers, supporters and partners. They were emotionally challenging for everyone who cares about The Kirkwood, not least because they included reducing the number of in-patient beds from 16 to 12 and reshaping services that had been developed over many years. We understood why those decisions were difficult to accept.
The changes challenged long-held assumptions about what The Kirkwood should look like and prompted understandable questions about our future. We asked our stakeholders to trust that the changes were proportionate, necessary and made with one purpose in mind: securing The Kirkwood's ability to care for people and communities long into the future.
This report allows us to reflect on what happened next.
Looking back, we remain confident that those decisions were the right ones. They created the stability we needed to look beyond immediate financial sustainability and focus on what matters most for our future: the difference we can make for local people and the communities we are here to serve. That is why this report is different from previous years.
The report is not simply a record of what happened during 2025–26. It explains why this year will matter long into the future.
Throughout the year, The Kirkwood continued to strengthen its financial position, invested in its facilities, restated its ambitions for income generation, reaffirmed and strengthened its partnerships across the health and care system, and undertook one of the most comprehensive engagement exercises in its history. Together, these achievements created something more valuable than organisational stability alone. They created the confidence to look ahead.
One message emerged consistently from the conversations we held across our communities. People do not define The Kirkwood simply by the services we provide. They define us by the quality of our human relationships; with patients and families, with colleagues and volunteers, with donors and customers, and with partners across our communities. That insight has shaped our new five-year strategy and our ambition for the future.
Some may look at this period and see a story of financial recovery. We see something different. We see a charity that has thoughtfully repositioned itself for a changing world while remaining true to the purpose that has guided us throughout our history. We see an organisation that has strengthened its foundations, renewed its confidence and is now looking forward with clarity and ambition.
The world will continue to change. Expectations of health and care will continue to evolve. New technologies, changing legislation and increasing pressures on public services will continue to shape the environment in which we work. Through all those changes, our responsibility remains the same: to bring our community together to care for people affected by life-limiting illness, helping them and their families to live well through to the end of life.
The year ahead will mark The Kirkwood's 40th anniversary. While it offers an opportunity to celebrate four decades of compassionate care, it is equally an opportunity to look forward with refreshed clarity and engage a new generation of supporters, volunteers and partners in shaping the future of end-of-life care.
3
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
We hope this report gives you confidence not only in what The Kirkwood has achieved over the past year, but in the future we are now building together.
Thank you for the trust, commitment and generosity that continue to make that future possible.
Michael Crowther Chief Executive
Lorraine Chapman Chair of the Board of Trustees
4
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026
Objectives and Activities
The Trustees who are the directors of Kirkwood Hospice for the purpose of company law, present the trustees annual report (including strategic report) and the audited financial statements of the charity for the year ended 31 March 2026.
The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Articles of Association and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
Kirkwood Hospice is a registered charity, number 512987 and a company limited by guarantee in England, number 01645888. The organisation was incorporated as a company limited by guarantee on 23 June 1982 and registered as a charity on 3 August 1982. The company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up members are required to contribute an amount not exceeding £10.
It should be noted that during the reporting period 1 April 2024 and 31 March 2025, the charity reviewed its Articles of Association. The last review had been conducted in 2013 and the trustees felt that as part of effective governance a review was required. On 8 August 2024, a special resolution was passed at a general meeting of the company. These revised Articles of Association were provided to Companies House and the Charity Commission and are therefore in the public domain.
Objects
The objects for which Kirkwood Hospice (referred to as The Kirkwood in this report) is established are to promote the relief of sickness by such charitable means as are considered appropriate; the governing documents define those charitable means in furtherance of those aims. There have been no material changes to these objectives since the last Annual Report.
Mission statement
To bring our community together to care people affected by life-limiting illnesses, helping them and their families to live well until the end of life.
Public benefit and eligibility criteria
The Charity Commission’s general guidance on public benefit has been used for reference when compiling this report and in planning future developments and activities.
The eligibility for our services is described below. In addition, The Kirkwood has further developed eligibility criteria for accessing In-Patient care at our hospice in Huddersfield. Common eligibility criteria were agreed in the year 2000 by all providers of specialist palliative care (SPC) working in Calderdale and Kirklees in order to ensure equity of access. These criteria reflect those adopted by other SPC services across Yorkshire. The three elements of the eligibility criteria are:
-
That patients should have active, progressive and potentially life-threatening illness.
-
That patients should have unresolved, complex needs that cannot be met by their current caring team, or it is anticipated that the patient will develop such needs in the near future. These needs may be psychological, social, spiritual, or physical.
-
Patients must have been recently assessed by a member of a Specialist Palliative Care team.
The trustees can confirm they have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the Charity’s aims and objectives and in planning future activities.
5
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Services provided
The Kirkwood helps local people, with an illness that cannot be cured, to live well and die with dignity and where possible in a place of their choice. We provide our services, free of charge, to people in Kirklees affected by life-limiting illnesses, focusing on their quality of life. We provide care for people affected by any life limiting illness, such as cancer, neurological conditions, advanced heart and lung diseases and dementia. We also provide services to patients’ families, carers and anyone that is important to them.
Most patients use a combination of services as their illness progresses and draw on the specialist skills of The Kirkwood’s multi-professional team, who work in collaboration with colleagues in all care settings to provide continuity of care. The Kirkwood also provide programmes of education to other professionals who are caring for people with life-limiting illnesses. In this way we seek to improve the quality of care experienced by all people who have palliative care needs.
Our services are continuously monitored, evaluated and reviewed to meet the changing needs of patients and their families. All our services are delivered considering current national guidance and quality statements and standards.
2025–26 at a glance
| Actvity Measure | 2024–25 | 2025–26 | Variance | % |
|---|---|---|---|---|
| People Supported | 2,702 | 2,196 | -506 | -19 |
| Patents Supported | 2,037 | 1,610 | -427 | -21 |
| Advice Line / Telephone Contacts | 11,438 | 11,884 | 446 | 4 |
| Home Visits | 3,757 | 3,274 | -483 | -13 |
| End of Life Patents Supported | 1,064 | 819 | -245 | -23 |
| Out of Hours Contacts | 979 | 1,343 | 364 | 37 |
| In-Patent Admissions | 318 | 271 | -47 | -15 |
| End of Life Patents in IPU | 225 | 202 | -23 | -10 |
| Out of Hours Admissions | 70 | 60 | -10 | -14 |
| Patent Experience Surveys Completed | 339 | 210 | -129 | -38 |
The world has changed. Our mission hasn't.
Some years are remembered for what happened. Others are remembered because they changed what happened next. We believe 2025–26 will be one of those years for The Kirkwood.
The Kirkwood was founded on a simple belief: that every person affected by a life-limiting illness deserves compassionate, expert care, and that no one should face the end of life alone.
That belief has not changed.
The world around it has.
People are living longer, often with increasingly complex needs. Medical knowledge continues to advance, bringing new treatments, technologies and opportunities that would have been unimaginable only a generation ago. At the same time, the expectations of individuals, families and communities continue to grow, rightly reflecting what is now possible.
6
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Yet there is an increasing gap between what health and care services could deliver and what they are able to deliver. Public finances remain under significant pressure; demand continues to grow and the people needed to provide care are increasingly stretched. These pressures are felt across health and social care, but perhaps nowhere more profoundly than in the support available to people living with frailty, serious illness and the practical realities of everyday life.
Alongside these challenges, society continues to ask new questions about the future of care. Advances in artificial intelligence have the potential to transform how health and care services are delivered, creating extraordinary opportunities to improve access, knowledge and personalisation. Equally, if implemented without careful thought, they have the potential to make care feel less personal and less human. At the same time, the national debate around assisted dying reflects changing expectations about dignity, choice and autonomy at the end of life. Whatever the outcome of these debates, they represent profound changes in the environment in which hospices now work.
Taken together, these developments create an important challenge. As the world becomes more complex, there is a risk that care becomes more fragmented, more transactional and less centred on the individual. For the communities, groups and individuals who have historically found it hardest to access care that understands their needs, those inequalities may become even more pronounced.
Against this backdrop, organisations like The Kirkwood become more important, not less. Our responsibility extends beyond delivering outstanding care today. It is to help define what outstanding end-of-life care should look like in the future, ensuring that compassion, dignity, equity, human relationships and meaningful connection remain at its heart.
This was the context in which The Kirkwood entered 2025–26. It was not simply a year in which we recovered from the difficult decisions that had secured our charity’s future. It was an opportunity to ask a more fundamental question: how should The Kirkwood fulfil its mission in a world that is changing so profoundly? The remainder of this report describes how we sought to answer that question.
A defining year
Looking back, 2025–26 will be remembered as the year we actively addressed our future. The previous year had required some of the most significant decisions in the charity's history. Those decisions were never intended simply to restore financial stability. Their purpose was to create the conditions for a different future: one in which The Kirkwood would be more sustainable, more influential and better equipped to meet the changing needs of the communities we serve.
Throughout 2025–26, that ambition began to take shape.
Rather than returning to business as usual, The Kirkwood continued to reposition itself around the needs of the future. We strengthened relationships with the NHS and health and care partners, helped shape a new integrated model of community palliative and end-of-life care, broadened our influence through partnerships with the local university, the voluntary sector and national organisations, and continued to make the case for a more sustainable approach to hospice funding.
This was not simply a year of external change. It was also a year of reflection.
The Kirkwood undertook the most comprehensive engagement exercise in our history, listening to patients and families, employees and volunteers, donors and customers, trustees, partners and the wider community. Those conversations were not simply about writing a strategy. They were about understanding what people valued most about The Kirkwood and the role they believed we should play in the future.
7
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Although people brought different perspectives, one theme emerged with remarkable consistency. People did not define The Kirkwood by its buildings or individual services. They defined us through the quality of our human relationships: the compassion we show to patients and families, the commitment of colleagues and volunteers, the generosity of donors and customers, and the strength of our partnerships across the community.
That insight became the foundation of The Kirkwood's new strategic direction.
The year also marked an important shift in confidence. Confidence that the difficult decisions taken previously had been the right ones. Confidence that The Kirkwood had a clear direction for the future. Confidence among partners that we would continue to play a leading role within the health and care system. Confidence among supporters that their generosity was helping to build something sustainable for future generations.
Looking back, these developments were not separate achievements. They were connected. Together they demonstrated that the changes made to secure The Kirkwood's future had also created the opportunity to redefine our contribution. Alongside the continuing commitment to delivering outstanding care, The Kirkwood increasingly has a role in helping to shape the future of end-of-life care across Kirklees, West Yorkshire and beyond.
If the previous year demonstrated the courage to change, then 2025–26 demonstrated why that change mattered.
Our response
The changing world described in the previous section required more than reflection. It required action. During 2025–26, The Kirkwood focused our efforts on a small number of strategic priorities. Together, these priorities completed our charity’s repositioning, strengthened our long-term sustainability and created the capacity to define our future with confidence.
The following priorities shaped the year's work and, collectively, created the conditions for the next chapter in The Kirkwood's development.
| Strategicpriority | Why it matered | Evidence |
|---|---|---|
| Complete our organisatonal repositoning |
Secure long-term fnancial sustainability while protectng the qualityand safetyof care. |
Financial balance achieved, revised clinical model embedded, organisatonal changes completed. |
| Strengthen our own income generaton |
Build greater confdence that increased care can be funded sustainably by our community over the longterm. |
Income ambitons restated, fundraising strengthened, retail transformaton progressed, online trading matured. |
| Invest in our future | Take advantage of one-of Government capital funding to improve the environment for patents,families and colleagues. |
Capital programme delivered. £609,721 invested. Projects completed. |
| Strengthen our role within the health and care system |
Help shape more integrated, sustainable models of specialist palliatve care. |
Integrated community model agreed, commissioning work undertaken, recurrent NHS funding secured, infuence across West Yorkshire expanded. |
| Defne our future directon |
Understand what people value most about The Kirkwood and build a strategy around that insight. |
Largest engagement exercise undertaken, new fve-year strategy developed, human relatonships identfed as defningcharacteristc. |
8
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Each of these priorities was achieved during the year. More importantly, together they demonstrated that the difficult decisions taken previously had achieved their purpose. They created the confidence and capacity for The Kirkwood to look beyond organisational sustainability and towards the future contribution we want to make to end-of-life care.
What we heard
Defining The Kirkwood's future was never going to be the work of a small group of people.
If our new strategy was to reflect the changing world around us, it first needed to reflect the people and communities we exist to serve.
During 2025–26, The Kirkwood undertook one of the most comprehensive engagement exercises in our history. Patients and families, employees, volunteers, donors and customers, trustees, health and care partners and members of our wider community all contributed their experiences, perspectives and ambitions for the future.
We were not seeking approval for a predetermined strategy, nor were we asking others to write it for us. We wanted to test our own thinking, challenge our assumptions and understand what people valued most about The Kirkwood.
The breadth of engagement is illustrated below.
The engagement process did not fundamentally change The Kirkwood's direction.
9
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Instead, it gave our charity the confidence to articulate something we had been working hard to build over many years.
Across every conversation, one idea emerged with remarkable consistency. People valued The Kirkwood not simply for the services we provide, but for the quality of the human relationships we create and the sense of connection those relationships foster – between patients and families, employees and volunteers, donors and customers, our communities and across the wider health and care system.
Those relationships are built on compassion, trust, dignity, expertise and a shared commitment to helping people live as well as possible until the end of life. They represent the unique contribution that The Kirkwood makes to our communities and the foundation upon which our future will be built.
That insight became the foundation of The Kirkwood's new five-year strategy.
Our future direction
Every strategic plan represents a series of choices.
It is not simply a statement of ambition. It is a decision about where an organisation can make the greatest difference in the (changing) world.
The engagement undertaken during 2025–26 gave The Kirkwood the confidence to make those choices with clarity. It confirmed that, while the world around us continues to evolve, the values that people associate with The Kirkwood have remained remarkably consistent. Compassion, dignity, trust, expertise and human connection are not simply characteristics of our care. They are the qualities that define our charity.
Our new five-year strategy therefore begins with a simple principle.
The Kirkwood's future will not be defined by the number and type of services we provide or the buildings we occupy. It will be defined by the quality of the human relationships we create and sustain.
This principle shapes every part of our future direction.
It means continuing to provide outstanding specialist palliative and end-of-life care while recognising that our contribution extends beyond the care we deliver directly. It means supporting and developing our employees and volunteers so they can build meaningful relationships with those they serve. It means creating deeper partnerships with the NHS, local authorities, education, research, businesses and the voluntary sector. It means inspiring deeper connection with our communities so that more people choose to support, champion and benefit from compassionate care in the future.
Above all, it means recognising that our responsibility is continuing to evolve.
As society changes, The Kirkwood will continue to champion compassionate, personalised and equitable end-of-life care. We will embrace innovation where it enhances quality of life, and strengthens human relationships, ensuring that advances in technology never come at the expense of humanity. We will continue to contribute to important conversations about the future of health and social care, helping to shape models of care that place people, relationships and communities at their centre.
As national policy continues to evolve, we are encouraged that many of the themes emerging through the NHS 10-Year Plan closely reflect the direction we have chosen. Greater integration, stronger community partnerships and a renewed focus on delivering more personalised care closer to home all reinforce the role that hospices like The Kirkwood can play within the future health and care system.
10
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Our strategy has been shaped by the needs of our communities, but it is reassuring that it also aligns with the wider direction of travel.
Our strategy is not simply about the next five years.
It is our commitment to ensuring that, whatever changes take place around us, The Kirkwood continues to be defined by what has always mattered most: helping people to live well through to the end of life, supported by the strength of human relationships.
How we will measure what matters
Every organisation measures performance. The Kirkwood is no different.
However, if our future is to be defined by the quality of the human relationships we create, then we must also ensure that we measure the things that matter most.
Many of the measures in this report will be familiar. They include the quality of our care, the experience of our people, the generosity of our supporters, the strength of our partnerships and our financial sustainability. These remain essential indicators of a healthy organisation.
Taken individually, however, they only tell part of the story.
Together, they provide something much more valuable. They help us understand whether patients, families, employees, volunteers, supporters, partners and our wider community continue to have confidence in The Kirkwood and the contribution we make.
As we deliver our new strategy, these are the areas in which we will continue to measure our progress and hold ourselves accountable.
| Confdence in.. | Why it maters | How we'll know |
|---|---|---|
| Care | Patents and families should experience compassionate, personalised and expert care throughout their journey. |
Patent and family feedback, clinical quality, CQC fndings, complaints and compliments. |
| Our people | The Kirkwood’s care depends on colleagues and volunteers feeling valued, supported and able to succeed. |
Engagement, retenton, sickness absence, volunteering, learning and development. |
| Support | Lastng relatonships with donors and customers enable more people to beneft from outstanding care. |
Donor retenton and value, lotery partcipaton, legacy giving, volunteer growth. Retail transactons and value. |
| Partnerships | Strong partnerships improve care and strengthen The Kirkwood's contributon to the wider system. |
NHS investment, commissioning relatonships, integrated community model, collaboratve programmes. |
| The future | Long-term confdence depends on sustainability, innovaton and delivering our strategy. |
Financial resilience, strategy delivery, capital investment, research and innovaton, income growth. |
These measures also help us understand whether people continue to feel connected to The Kirkwood and our mission.
11
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
Review of Financial Activities
The Consolidated Statement of Financial Activities for the accounting period is detailed on page 35 of the financial statements. A summary of the financial results and the work of The Kirkwood is set out below.
Summary of financial performance
-
Income for the accounting period increased from £10,904,028 for the year to 31 March 2025 to £13,835,231 (27%) for the year to 31 March 2026.
-
Expenditure for the accounting period decreased from £11,550,894 for the year to 31 March 2025 to £11,462,302 (0.76%) for the year to 31 March 2026.
-
The operating surplus for the accounting period before considering gains and losses on investments amounted to £2,372,929 compared to last year’s deficit of £646,866.
-
The total surplus for the accounting period was £2,574,377 in comparison to a deficit of £504,072.
-
The positive financial position at the end of the accounting period is attributed to higher-thanexpected legacy income, an unexpected increase in NHS funding and significant capital grant funding from Hospice UK (HUK). It is important to note that without these exceptional items the charity would have achieved a breakeven position.
The Kirkwood entered 2025–26 facing significant financial challenges and the need to implement organisational change to secure long-term sustainability. Trustees therefore adopted a disciplined approach to financial management, balancing the need to reduce expenditure with the continued delivery of safe, high-quality care. Through strong financial oversight, organisational transformation and improved income performance, the charity's financial position improved significantly during the year.
Monies Received
Income performance exceeded expectations across several key areas. Total income was £13,835,231, compared with a budget of £10,632,581, representing an increase of £3,317,801 against plan. This was driven by several factors, including exceptional legacy income, increased community fundraising income, additional support from the NHS and Integrated Care Board, and the Hospice UK capital funding programme.
Legacy income delivered one of the strongest performances in the charity's history. The charity also benefited from over £662,000 of non-recurrent NHS funding (which was confirmed as recurrent at the end of the reporting period) and approximately £610,000 of HUK capital grant funding, enabling additional investment in facilities and infrastructure. We can confirm that the grant monies were expended and claimed as required in the grant agreement.
Whilst overall income performance was strong, some income streams experienced challenges during the year. Income received from charitable trusts and foundations was below target, primarily because a significant number of planned capital projects were funded through the Hospice UK capital programme rather than through traditional grant-making organisations. Event income was also lower than budget, although this was offset by stronger performance in community fundraising, lottery income and regular giving.
Donations and gifts continue to form a substantial portion of our income, and we deeply appreciate the support of individual and corporate donors, charitable trusts, and all our supporters. We are especially grateful to those who chose to remember The Kirkwood in their Wills, leaving a legacy to the charity. During the year, legacy contributions amounted to an amazing £2,923,515.
Income received is detailed from Notes 2 to 5 of the accounts.
12
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Monies expended
Total expenditure for the year was £11,462,302 against a budget of £10,826,213, resulting in an overspend of £636,089. This variation was driven by additional, unplanned funding from the ICB and HUK that was not known when the budget was set. Specifically, pay budgets exceeded plan due to temporary recruitment for new posts funded by a £662k non-recurrent allocation from the ICB. Additionally, the HUK grant funding brought forward proposed expenditure from future years, which will significantly increase depreciation costs over the next four years.
The costs for various services are detailed in Note 6 of the accounts.
Financial Position
As a result of strong income performance, The Kirkwood moved from reporting operating deficits in previous years to delivering a healthy operating surplus in 2025–26. Forecasts reported to Trustees indicate that the charity has returned to a financially balanced position, placing The Kirkwood on a stronger footing to invest in our strategic priorities and continue providing outstanding care to patients and families across Kirklees.
Overall, 2025–26 marked an important turning point for The Kirkwood. Through difficult but necessary decisions, combined with the extraordinary generosity of supporters, additional statutory investment and the commitment of employees and volunteers, the charity finished the year in a significantly stronger financial position than anticipated, providing a stable platform from which to deliver our new 2026-2031 Strategy.
Reserves
The Executive Management Team monitors the level of reserves held monthly when reviewing the management accounts. This information is subsequently reported into Finance and Resources Committee on a quarterly basis. Forecasts of income and expenditure are made annually, with the aim of balancing expenditure and income to ensure our services are sustainable into the future.
The Finance and Resources Committee reviews the reserves policy each year. In conducting the review, they take into consideration best practice and the guidance issued by the Charity Commission (CC19 Charities and Reserves). The review is reported to the Board of Trustees at its next meeting and recorded in the minutes.
The charity determines reserve requirements through a risk assessment of income and expenditure, rather than setting a minimum reserve level based on months of expenditure. This calculation considers legal and statutory obligations, as well as the aims and objectives outlined in The Kirkwood’s Finance Strategy.
The Charity’s reserves have been built up during the years when income exceeded expenditure. The reserves are made up of fixed assets and general funds. These general funds are invested and are available to bridge years when income does not cover costs, or to fund service developments and short-term service needs. The Investment Sub-Committee monitors the performance and management of investments held by the charity’s investment manager on a quarterly basis and routinely reviews the charity’s risk tolerance. Throughout the financial year, the investment portfolio was managed within a medium-risk mandate.
The Kirkwood’s Investment Management Policy includes ethical investment. The charity continues to work with its investment managers to align the portfolio with these principles.
13
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
The total funds held by the charity as of 31 March 2026 were £11,837,216 in comparison to £9,262,839 and included restricted funds of £59,382 and Endowment Funds of £6,115.
After deducting restricted funds, endowment funds and funds held as functional assets (£4,273,185), the charity had free reserves of £7,498,534 in comparison to £5,168,125 at the end of 2024–25. Free reserves are held to provide The Kirkwood with a contingency to endure unexpected events that significantly impact our financial position. At the end of the accounting period, they represented five months future expenditure.
The increase in free reserves shows the significant impact of additional funding received during the accounting period.
The statement of funds can be viewed at Note 23 on pages 51 to 53 of this document.
Structure, governance and management
The governing body of The Kirkwood is the Board of Trustees. As of 31 March 2026, The Kirkwood Board comprised eleven Trustee members who meet four times per annum. There are committees dealing with Clinical Governance, Finance and Resources, Income Generation and Marketing, Nominations, Risk & Audit, Remuneration, Community Development and Engagement (CDE) and other specific referrals from the Board of Trustees. Day to day operational delivery and management is delegated to the Chief Executive. The salary of the Chief Executive is determined by the Trustees with advice from the Remuneration Committee on the Chief Executive appointment and by periodic reviews conducted by the Chair of Trustees. The salaries of the other members of the Executive Management Team are determined by the Chief Executive.
The Trustees are dedicated volunteers who bring a diverse range of skills, experiences and background. Individuals can join the board either by expressing their interest in serving as trustees or through The Kirkwood’s open trustee recruitment process. This process begins when a skills gap is identified, specifying the knowledge and skills the charity seeks. After a successful interview and satisfactory due diligence checks, new trustees are appointed at the next scheduled Board of Trustees meeting.
Each new trustee undergoes a formal induction programme to become familiar with all aspects of The Kirkwood’s governance, strategy and operations. Additionally, Trustees must complete relevant mandatory training and participate in formal annual review meetings with the Chair of Trustees. Trustees do not receive any benefits from the charity and are required to complete an annual declaration of interests.
Trustees serve a three-year term from their appointment, after which they are eligible for re-appointment. Trustee tenure is monitored by the Nominations Committee, which makes re-appointment recommendations (including extensions to terms of office), to the Board of Trustees.
Kirkwood Hospice Enterprises is a registered company limited by guarantee in England, number 07368034. This is a trading subsidiary of the charity and was incorporated as a company limited by guarantee on 7[th] September 2010. The company was established under a Memorandum and Articles of Association.
The principal activity of the company is to generate income for the parent company Kirkwood Hospice from trading activities for commercial and income generating purposes.
The trading subsidiary is a separate legal entity from the charity and therefore needs its own board of directors. Because it has a different purpose from the charity (to carry out for profit trading), it requires individuals with different skills and backgrounds from the charity trustees. The trading company operates at ‘arm’s length’ from the charity, but a small overlap between the two boards is required to ensure that opportunities and risks are managed from a governance perspective.
14
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
Kirkwood Hospice Enterprises board is made up of the following:
-
2 Trustees of the charity (one being the Chair of the Income Generation and Marketing Committee)
-
2 Employees of the charity (Director of Fundraising & Marketing and the Director of Finances and Resources)
-
Independent Individuals (minimum of 2)
The Chief Executive and the Chair of Trustees are permitted to occasionally attend trading company board meetings, but this is for observation only – they cannot be part of the decision making and do not have any voting rights at these meetings.
As a separate legal entity, the trading company is required to have separate board meetings, which are separately minuted. Systems must be established to ensure that the charity monitors the performance of the trading subsidiary. Therefore, copies of the minutes of the trading company board meetings and management accounts are made available and considered at the Income Generation and Marketing Committee meetings of the charity. A director of the trading subsidiary who is a charity trustee or employee has responsibility for reporting on the activities of the trading company at each committee meeting.
Trustee responsibilities
The directors of the charitable company are its Trustees for the purposes of charity law. The Trustees who have served during the year were as follows:
Mrs C Black Miss L A Chapman Prof J Davies Mr E Johnson Mrs P McSorley Prof P W Roberts OBE Mr P R Sands Mr P L Scovell Resigned 6[th] November 2025 Dr I R Wilson Mrs C Green Mrs S Bryson Mr Mohammed Zabed
The charity holds an indemnity insurance policy on behalf of its trustees. Details of the cost are included in note 11 to the financial statements. The Board Members (who are also directors of The Kirkwood for the purposes of company law) are responsible for preparing the Trustees’ Annual Report, including the Strategic Report, and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period.
In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently.
-
observe the methods and principles in the Charities SORP 2015 (FRS 102)
-
make judgements and estimates that are reasonable and prudent.
-
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements.
15
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued )
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.
The Trustees are responsible for keeping adequate accounting records that disclose, with reasonable accuracy at any time, the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the company’s website. Legislation in the United Kingdom governing the preparation and dissemination of the financial statements may differ from legislation in other jurisdictions.
Community, Development and Engagement
Becoming more diverse is completely aligned with why The Kirkwood exists: ‘to bring our community together to care people affected by life-limiting illnesses, helping them and their families to live well until the end of life.’ The Kirkwood’s services are available to people based on need and not individual identity. Our ethos is to meet individual needs, through personalised care and the promotion of dignity for all our patients and those important to them. We cannot achieve this unless we connect with people on a human level to understand what matters to them most.
The people we exist to serve are individuals with their own unique identities. We must develop our services to meet their needs in ways that are more accessible so that people feel they belong within our movement. The time is right to address inequalities in the care that we provide, and communities are more enthusiastic to engage now than ever before.
In terms of employment, The Kirkwood is committed to ensuring equity of opportunity for our employees. The Kirkwood believes that selection and promotion should be based solely on ability to meet the requirements of the post. The aim is to provide equal access to jobs and training, and to ensure that all employees enjoy the full benefits of working for the charity. The Kirkwood does not discriminate on the grounds of age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, sex, religion or belief.
Planning consultation and communication
The Executive Management Team comprises the Chief Executive, the Director of Finance and Resources, the Director of Clinical Services, the Medical Director, the Director of Fundraising and Marketing and the Associate Director of Retail. The Executive Team meet weekly and work within overall strategic objectives and policy guidelines determined by the Trustees. The Chair of Trustees meets regularly with the Chief Executive, and the Executive Management Team attend Board and Committee meetings.
All management initiatives involve employees and volunteers in forward planning. Employee views are sought via an Employee Voice Forum, where operational developments and changes to terms and conditions of employment are contemplated. Employees contribute to and regularly receive internal communications and other memoranda to inform them of developments and changes.
Fundraising Standards
The Kirkwood works hard to meet the requirements of the Fundraising Regulator (of which it is a paid-up member), and to follow these standards when planning or undertaking fundraising initiatives. This includes supporting donors who are planning or undertaking their own fundraising initiatives to ensure that they are conducted ethically, and within the law. In addition, donations received are processed following the charity’s comprehensive Internal Financial Control Procedures in line with Charity Commission guidance.
16
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Support groups are branches who undertake their own fundraising initiatives in support of The Kirkwood. They have their own committees, whose accounts are incorporated into The Kirkwood’s annual accounts.
All income generation activities are undertaken within charity law, Charity Commission guidelines, the Fundraising Regulator’s Codes of Practice, HMRC rules, The Gambling Act, local licensing laws, Advertising Standards Authority rules and Data Protection legislation (this list is not exhaustive). The Kirkwood never sells donor data to a third party, or engages in data swapping, and a statement to this effect is included in our fundraising literature.
However, The Kirkwood sees compliance with legislation and codes of practice as a minimum standard, not an aspiration, and we strive to ensure our supporter care is of the same high standard as the care we offer our beneficiaries. We hope our supporters enjoy and value their interactions with the charity, look forward to receiving information from us, and know we view them as partners in the care we can offer. We work towards these goals throughout all our income generating activity.
During this accounting period there was only 1 complaint in relation to our income generation activities. Employees and volunteers are empowered to deal positively and respectfully with any complaint. The charity has an effective, open and accessible Complaints Policy. We also have systems and procedures which promote learning within the organisation and aim to maintain the excellent reputation of the charity. All complaints are audited on a quarterly basis.
Protecting Vulnerable People
The Kirkwood ensures our colleagues and volunteers are fully briefed about the protection of vulnerable people. We brief staff and volunteers about best practice before they undertake any fundraising, making them aware of the need to identify, respect, support and protect vulnerable people. We have safeguarding polices in place and all our fundraising employees have undertaken safeguarding adults and children training.
Colleagues employed by The Kirkwood carry out most of our fundraising activities. For some activities, we work with other organisations or individuals to assist with our fundraising. For example, we work with lottery canvassers for lottery sign-ups. All arrangements are governed by written agreements that cover the responsibilities of both parties to ensure that anyone working on our behalf adheres to our strict ethical standards. We take all reasonable steps to protect vulnerable people.
When seeking to raise money from the public, we only send marketing material to those who have previously said they are happy to be contacted by us (and individuals are free to change their minds at any time). We take great care to ensure that our level of communication with our supporters is proportional and appropriate.
The charity does not condone and never employs aggressive fundraising tactics. All contact with donors is conducted in a caring and professional manner, in line with The Kirkwood’s values.
Risk Management Review and Principal Risks
The Board of Trustees is responsible for ensuring that The Kirkwood has effective systems in place to identify, manage and mitigate the principal risks that could affect delivery of our charitable objectives.
The Board Assurance Framework remains a key tool for strategic oversight. It brings together the principal risks that could significantly affect The Kirkwood’s ability to deliver our strategy, the controls and assurances in place, and any actions required to strengthen risk management. Each strategic risk has an identified Executive Management Team lead, with strategic ownership retained by the Board of Trustees or one of its committees.
17
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
During the year, Trustees also began considering how strategic assurance should evolve in light of our 2026– 2031 Strategy. The discussion paper presented to the Risk and Audit Committee recognised that the operating environment has changed significantly since the current Board Assurance Framework was developed, with the strategy refresh, stakeholder engagement, SWOT analysis and geopolitical risk assessment highlighting new priorities, opportunities and uncertainties.
The future approach to strategic assurance is expected to be more closely aligned to the new strategy, with risks derived from the question: “What must be true if The Kirkwood is to achieve its strategic ambitions over the next five years?” This means the Board Assurance Framework will increasingly focus on the smaller number of principal uncertainties that could significantly affect strategic delivery, while operational, compliance and specialist risks may be managed through appropriate supporting frameworks and governance arrangements.
Comparison of Principal Risks: 2024–25 and 2025–26
The principal risks reported at the end of 2024–25 reflected a period of organisational change, financial pressure, workforce uncertainty and the need to protect stakeholder confidence. The 2025–26 review shows that these themes remain important, but the nature of some risks has shifted. In particular, the focus has moved from implementing urgent financial and organisational change towards embedding new operating models, maintaining confidence, strengthening leadership capacity and delivering the new 2026– 2031 Strategy.
| Risk theme | 2024–25position | 2025–26position | Direction of travel |
|---|---|---|---|
| Workforce, culture and capacity |
Workforce risk was identified as one of the highest scoring risks, linked to recruitment, retention, skills, behaviour, employee vacancies and attrition. The 2024–25 narrative recognised sector-wide workforce challenges, post-pandemic exhaustion, cost-of-living pressures and the impact of organisational change. |
Workforce remains a principal risk, but the emphasis has shifted towards organisational confidence, morale, leadership capacity and the need to sustain engagement following a prolonged period of change. The 2025–26 strategic response includes Change Communities, the Employee Voice Group, the Senior Leadership Community, workforce planning, leadership development and employee wellbeing. |
Continuing risk, reframed from vacancies and attrition towards culture, confidence and leadership capacity. |
| Financial sustainability and reserves |
The 2024–25 financial risk was described as the charity’s income not covering the cost of providing services, with concern that reserves could fall below legal and moral obligations. The risk narrative referred to an organisational change programme to reduce expenditure by £1.7m, reductions in practical and social support elements, reductions in corporate and support services,and a |
Financial sustainability remains a principal risk, but the 2025– 26 review states that the organisation’s financial position strengthened significantly during the year, and that additional NHS funding was secured. The main risk is now the longer-term need to generate sufficient recurring income to meet rising demand, increasing costs and the ambitions of the new strategic framework. |
Improved immediate position, but continuing long- term risk around recurring income and sustainability. |
18
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Risk theme | 2024–25position | 2025–26position | Direction of travel |
|---|---|---|---|
| reduction in In-Patient Unit beds from 16 to 12. |
|||
| Fundraising and voluntary income |
In 2024–25, a separate risk was identified around failure to achieve the required fundraising and voluntary income contribution. The title of this risk was “The Kirkwood’s Income does not cover the costs of providing services - Failure to achieve required Fundraising (voluntary / non-statutory) contribution”. |
In 2025–26, this risk has been consolidated into the broader financial sustainability risk. The 2025–26 review recognises continued dependence on voluntary income, donations, fundraising activity, retail contribution, grants and legacy income, with legacy income noted as important but unpredictable. |
Consolidated into the wider sustainable funding model risk. |
| Management effectiveness and organisational capacity |
The current Board Assurance Framework includes ineffective management of the organisation as a strategic risk. |
In 2025–26, this is one of the top five principal risks. The review states that the risk is not the development of strategy itself, but the ability to embed change, maintain organisational alignment and translate strategic ambition into consistent delivery. The response includes strengthening leadership capacity, establishing a Senior Leadership Community, developing Change Communities and investing in enablingfunctions. |
Increased prominence as the organisation moves from change implementation to strategic delivery. |
| Reputation and stakeholder trust |
In 2024–25, reputational risk was linked to organisational change and possible bad publicity. The narrative referred to changes implemented to reduce expenditure by £1.7m, including service and staffing reductions. It also highlighted the need to maintain stakeholder confidence through proactive communication, FAQs, engagement forums and monitoring of indicators such as self-referrals, recruitment interest, donor behaviour and patient feedback. |
In 2025–26, reputation remains a principal risk. The emphasis is on how stakeholders understand the interaction between difficult organisational change, later financial improvement, significant legacy income, additional non- recurrent funding and increased NHS investment. The Board and Executive Management Team remain confident the decisions taken were necessary to protect long- term sustainability of the charity. |
Continuing risk, with focus now on transparency, interpretation, confidence and involvement. |
| Loss of or imposed change to strategic direction |
In 2024–25, this risk included external influences on strategic direction, with assisted dying specifically referenced in the list of top risks shared ahead of the CQC inspection. |
In 2025–26, this remains one of the top five risks. The review describes a wider external environment shaped by health and care policy, commissioning arrangements, technology, public expectations, economic conditions, integrated neighbourhood approaches, |
Continuing risk, broadened beyond individual policy issues to wider external change and adaptability. |
19
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Risk theme | 2024–25position | 2025–26position | Direction of travel |
|---|---|---|---|
| Artificial Intelligence, workforce transformation and potential legislative change. |
|||
| Business continuity, cyber, data, health and safety and specialist assurance |
The current Board Assurance Framework includes business continuity, data and IT capability, and health and safety assurance as strategic risk areas. |
The Risk and Audit Committee proposes that some specialist risks may be better managed through supporting assurance frameworks, including business continuity, cyber security, data protection and information governance, digital infrastructure, health and safety, clinical quality, safeguarding, regulatory compliance and estates resilience. |
Likely to move into supporting assurance frameworks rather than remain as principal BAF risks. |
Current Principal Risks Being Managed (as of 31[st] March 2026)
At the end of 2025–26, the five highest scoring risks identified for Annual Report disclosure were all scored at 12 on the 1 to 25 scale. These risks were: workforce numbers, skills or behaviour; income not covering the cost of services; ineffective management; negative impact on reputation; and loss of or imposed change to strategic direction.
| Key Risk at the end of | Key Risk at the end of | Commentary | Risk |
|---|---|---|---|
| Accountng period | Score | ||
| 2025–26 | (1 – 25) | ||
| 1 | Inadequate Workforce Numbers, Skills, or Behaviour |
Like many organisatons across the health, care and charity sectors, The Kirkwood contnues to operate within a challenging workforce environment. While recruitment actvity has remained positve and workforce turnover has stabilised during the year, the most signifcant workforce risk at the end of 2025–26 relates to organisatonal confdence, morale and leadership capacity following a period of organisatonal change. The changes required to restore fnancial sustainability were successfully implemented during the year. However, periods of signifcant change can create uncertainty and place pressure on workforce engagement, organisatonal culture and leadership capacity. There is a risk that, if not actvely addressed, these factors could afect our ability to successfully implement our new Strategic Framework, sustain workforce commitment and maintain the high standards of care and support expected by our patents, families, supporters and communites. The Kirkwood's strategic response is focused on strengthening employee engagement, leadership capability and organisatonal culture. During 2026–27 we will increase opportunites for colleagues and volunteers to infuence the future directon of the organisaton through the development of Change Communites, the Employee Voice Group and the Senior Leadership Community. These initatves are intended to strengthen communicaton, build confdence, encourage collaboraton and reinforce a compassionate culture where human relatonships remain central to how we work. |
12 |
20
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Key Risk at the end of | Key Risk at the end of | Commentary | Risk |
|---|---|---|---|
| Accountng period | Score | ||
| 2025–26 | (1 – 25) | ||
| Alongside this, we contnue to invest in workforce planning, recruitment, leadership development and employee wellbeing to ensure The Kirkwood remains an atractve place to work and volunteer, capable of delivering our mission and strategic ambitons into the future. |
|||
| 2 | The Kirkwood's Income does not cover the costs of providing services |
The Kirkwood relies on a combinaton of NHS funding, charitable donatons, fundraising actvity, retail contributon, grants and legacy income to deliver our services. While the charity’s fnancial positon strengthened signifcantly during 2025–26, and additonal NHS funding was secured, the charity remains dependent upon voluntary income to fund a substantal proporton of the care and support we provide. The principal fnancial risk at the end of 2025–26 is not immediate fnancial stability, but the longer-term challenge of generatng sufcient recurring income to meet rising demand, increasing costs and the ambitons set out within our new Strategic Framework. While legacy income remains an important source of funding, it can be unpredictable and cannot be relied upon as the sole soluton to future fnancial pressures. The Kirkwood's strategic response is focused on building a more sustainable and balanced funding model. This includes contnuing to demonstrate the value of hospice care to health and care partners, supportng further investment in services, while strengthening long- term relatonships with supporters, volunteers, donors and local communites. During the year, work contnued to modernise fundraising and retail operatons, alongside exploraton of how technology and Artfcial Intelligence can support deeper and more personalised engagement with those who choose to support our work. At the heart of our approach is a simple principle: the future sustainability of The Kirkwood depends upon maintaining strong and enduring relatonships with the community that provides the funding which makes our care possible. We remain commited to earning and retaining that support through transparency, impact and meaningful engagement. |
12 |
| 3 | The Management of The Kirkwood is Inefectve |
The Kirkwood has experienced a period of signifcant organisatonal change during recent years, including the implementaton of a major fnancial sustainability programme, the redesign of services and workforce structures, the development of a new integrated clinical model, and the approval of a new Strategic Framework for 2026–2031. While these developments have put us in a much stronger positon for the future, they also create a risk that the pace and complexity of change could outstrip organisatonal capacity and afect successful delivery. At the end of 2025–26, the principal management risk is not the development of strategy, but the organisaton's ability to efectvely embed change, maintain organisatonal alignment and translate strategic ambiton into consistent delivery. This ispartcularly |
12 |
21
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Key Risk at the end of | Key Risk at the end of | Commentary | Risk |
|---|---|---|---|
| Accountng period | Score | ||
| 2025–26 | (1 – 25) | ||
| important as The Kirkwood moves from a period of consolidaton into one of implementaton, growth and service development. The Kirkwood's strategic response is focused on strengthening leadership capacity, capability and resilience across the organisaton. During 2026-27, we will establish a Senior Leadership Community to improve organisatonal alignment, communicaton and shared leadership, while increasing opportunites for distributed leadership through the development of Change Communites. Additonal investment is also being made in key enabling functons, including people and culture, workforce engagement and communicatons. By strengthening leadership at all levels of the organisaton, we aim to ensure that The Kirkwood has the capacity, capability and culture required to successfully deliver its strategic ambitons while maintaining the high standards of care, support and stewardship expected byour stakeholders. |
|||
| 4 | The Kirkwood's Reputaton is Afected Negatvely |
The Kirkwood's reputaton is one of its most important assets. The trust and confdence placed in the charity by patents and families, employees and volunteers, supporters, partners and the wider community are fundamental to our ability to deliver care and fulfl our mission. At the end of 2025–26, the principal reputatonal risk relates to how stakeholders interpret a period of signifcant organisatonal change and the outcomes that followed. During 2024–25 and 2025–26, The Kirkwood implemented difcult but necessary changes to restore fnancial sustainability in response to rising costs, increasing demand and wider pressures afectng hospices across the country. At the same tme, the charity contnued to pursue a number of long-term strategic objectves, including securing additonal NHS investment and strengthening our positon within the wider health and care system. As a result of successful delivery of these strategies, combined with exceptonal community support, signifcant legacy income and additonal non-recurrent funding, The Kirkwood completed the year in a much stronger fnancial positon than antcipated. There is a risk that the tming and interacton of these factors is not fully understood and that some stakeholders may conclude that the changes implemented were unnecessary or went further than required. The Board and Executve Management Team remain confdent that the decisions taken were necessary to protect the long-term sustainability of the charity and ensure that patents and families remained at the centre of decision-making throughout. Our strategic response is focused on contnued openness, transparency and meaningful engagement with all stakeholder groups. We are commited to sharing both the successes and challenges experienced during this period, listening carefully to feedback and involving people in shaping the future of The Kirkwood. This approach will be strengthened through |
12 |
22
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
| Key Risk at the end of | Key Risk at the end of | Commentary | Risk |
|---|---|---|---|
| Accountng period | Score | ||
| 2025–26 | (1 – 25) | ||
| implementaton of the new Strategic Framework, the development of Change Communites and engagement actvites linked to The Kirkwood's forthcoming 40th anniversary. We believe that trust is built through transparency, consistency and involvement. By contnuing to engage openly with our community and demonstratng the impact of our work, we aim to maintain the confdence that underpins The Kirkwood's reputaton and long-term success. |
|||
| 5 | Loss of or Imposed Change to Strategic Directon |
The environment in which The Kirkwood operates contnues to evolve rapidly. Changes in health and care policy, commissioning arrangements, technology, public expectatons and wider economic conditons all have the potental to infuence the future directon of hospice and palliatve care services. There is a risk that signifcant external changes could alter the context in which The Kirkwood delivers our mission or create pressures that require adaptaton of strategic priorites and operatng models. At the end of 2025–26, this risk is partcularly relevant as health and care systems contnue to develop integrated neighbourhood approaches, expectatons regarding community-based care increase, and wider societal conversatons about death, dying and end-of-life care contnue to evolve. Developments in areas such as Artfcial Intelligence, workforce transformaton and future legislatve change may also shape expectatons of how care is delivered in the future. The Kirkwood's strategic response is to remain actvely engaged in shaping, rather than simply responding to, these developments. We contnue to strengthen our infuence through partnership working, system leadership and collaboraton with organisatons across the health, care, academic and voluntary sectors. During the year, this included contnued leadership within the health and care system, development of strategic partnerships and exploraton of opportunites to strengthen research, innovaton and evidence generaton. Our ambiton is to remain a trusted voice for end-of-life care and to ensure that the needs of patents, families and communites are represented within emerging policy and service developments. By maintaining strong relatonships, investng in learning and remaining adaptable, we aim to ensure that The Kirkwood is well positoned to respond to future change while remaining true to our mission, values andpurpose. |
12 |
Special acknowledgement
The Trustees would like to express their sincere thanks to the thousands of people who make up The Kirkwood Movement. Patients and families, employees, volunteers, supporters, donors, customers, fundraisers, partners and local organisations have all contributed during an important year for our charity.
Their support has helped The Kirkwood move forward with renewed confidence following the significant changes of the previous year. Whether through giving time, raising money, sharing expertise, working in partnership, shopping with us, advocating for our work or helping us understand what matters most, every
23
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
contribution has strengthened our ability to care for people affected by life-limiting illness and build for the future.
Our supporters and fundraisers
The generosity of our local communities remains fundamental to what makes The Kirkwood the charity it is. The Trustees thank everyone who has donated, fundraised, played The Kirkwood Lottery, supported our shops, volunteered at an event, taken on a challenge, left a gift in their Will or made a regular donation.
We particularly recognise:
-
The Ultimate Ball, organised for the first time by a committed group of fundraisers, raising over £50,000 in support of The Kirkwood.
-
The Albert Hunt Trust, whose generous support of £30,000 has enabled specific projects to be delivered.
-
Holmfirth Art Week, for their continued support of our work including a donation of £20,000 from their event.
-
Hanging Heaton Golf Club, which raised more than £34,000 through its Charity of the Year fundraising.
-
Reliance Precision Ltd and SB Homes Ltd, each helping to raise more than £11,000 through their fundraising activities.
-
The Kirkwood Community support groups in Batley and Birstall, Meltham and Holmfirth, Team Serenity and Sarah’s Wish for Kirkwood, for their continuing fundraising, advocacy and connection with communities across Kirklees.
-
Everyone who supports The Kirkwood regularly through the Lottery and regular giving donations, providing dependable income that helps us plan confidently for the future.
-
Our retail customers, donors and volunteers, whose continued support of our shops contributes both to our income and our connection with communities across Kirklees.
And finally, HM Government for providing £609,721 of capital funding via Hospice UK, supporting improvements to our facilities and infrastructure and helping ensure they remain fit for the future.
Our employees and volunteers
The Trustees thank every employee and volunteer for the commitment, compassion and professionalism they have shown throughout the year.
Following the organisational changes of the previous year, colleagues have established new ways of working while remaining focused on providing outstanding care and support to patients and families. Our volunteers continue to make an extraordinary contribution across our clinical services, shops, fundraising, governance and communities. The Kirkwood simply could not achieve what it does without them.
We also warmly welcome everyone who joined The Kirkwood as an employee or volunteer during 2025–26.
The organisational changes meant saying goodbye to a number of long-serving colleagues. Some left following changes to roles and services, while others made personal decisions that helped the organisation navigate a difficult period. The Trustees are particularly grateful for the generosity, professionalism and commitment shown throughout this time.
We particularly recognise the following colleagues and volunteers who left during the year after many years of dedicated service:
24
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
-
Patricia Boyd, Retail Volunteer – Huddersfield, after 25 years of service
-
Joanne Martin, Personal Assistant, after 23 years of service
-
Rosemary Holland, Clinical Nurse Specialist, after 22 years of service
-
Janet Bowman, Staff Nurse, after 22 years of service
During the year, we also experienced the sadness of losing colleagues and volunteers who had been part of The Kirkwood community. We remember Diane Susan Simmons, Shirley Armitage, Andrea Buckley and Susan Dickinson with great affection and gratitude. Our thoughts remain with their families, friends and everyone across The Kirkwood who knew and worked alongside them.
Our partners
Partnership has been particularly important during 2025–26. Working together helped The Kirkwood develop its integrated community model, expand community nursing, support the development of the Virtual Hospice, restore in-patient capacity to 16 beds and secure additional recurrent NHS investment.
We particularly thank NHS West Yorkshire Integrated Care Board, Calderdale and Huddersfield NHS Foundation Trust, Mid Yorkshire Teaching NHS Trust, Locala Health and Wellbeing, Kirklees Council and our wider health and care partners for their commitment to improving care for people affected by life-limiting illness.
We are also grateful to colleagues across the West Yorkshire Hospice Collaborative and NHS partners across West Yorkshire for their continuing work to develop a more sustainable approach to hospice and specialist palliative care, focused on the contribution hospices can make to the future of end-of-life care.
Our partnership with the University of Huddersfield continues to support our ambitions for research, education, workforce development and innovation, and we are grateful for the University's continued commitment to The Kirkwood.
Shaping our future together
This year, more people than ever contributed their ideas and experience to conversations about The Kirkwood's future. We thank everyone who participated in workshops, surveys, focus groups and conversations during the development of our new five-year strategy.
We particularly thank the members of our Strategy Review Steering Group: Asma Sacha, Helen Carr, Helen Woodhead, James Creegan, Jan Thornton, Jayne Anderson, Michelle Cowan, Sadaf Adnan, Ruth Allen and Sunita Morris.
Together, these contributions helped confirm something that has been central to The Kirkwood for many years: our future will be defined not simply by buildings or services, but by the quality of the human relationships and connections we create.
Finally, the Trustees thank the charitable trusts and foundations, businesses, professional advisers, community organisations and many other partners who have supported The Kirkwood throughout 2025– 26.
Every contribution is different, and together they make outstanding care possible and give The Kirkwood the confidence to continue building for the future.
25
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Trustees' Annual Report for the year ended 31 March 2026 (continued)
Financial Instruments
The Kirkwood’s principal financial instruments comprise bank balances, an investment portfolio, trade creditors and trade debtors. The main purpose of these instruments is to raise funds for the operations of the charity and to finance The Kirkwood’s Services.
Due to the nature of the financial instruments used by the charity, there is no exposure to price risk other than that which relates to the investment portfolio. To manage this risk, the Finance and Resources Committee (Investment Sub-Committee) meet at quarterly intervals with the investment managers to review performance in the light of the investment management policy. The Kirkwood’s approach to managing other risks applicable to the financial instruments concerned is shown below.
In respect of bank balances, the liquidity risk is managed by maintaining credit balances. The Kirkwood makes use of money market facilities when funds are available.
Trade debtors are managed by the regular monitoring of amounts outstanding for both time and credit limits.
Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts falling due.
26
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
Charity References and Administrative Details
Charity registration number 512987
Company registration number 01645888
Trustees as of 31[st] March 2026
Mrs C Black Miss L A Chapman Prof J Davies Mr E Johnson Mrs P McSorley Prof P W Roberts OBE Mr P R Sands Dr I R Wilson Mrs C Green Mrs S Bryson Mr Mohammed Zabed
Life President
Mr D N Stocks
Chair of Trustees Miss L A Chapman
Company Secretary and Registered Office Mrs P E Wade DChA FMAAT 21 Albany Road Dalton Huddersfield HD5 9UY
Chief Executive Mr M Crowther BA(Hons) PgDip
Director of Finance and Resources Mrs P E Wade DChA FMAAT
Director of Clinical Services Mrs L Hall-Bentley RGN/RSCN
Medical Director
Dr S Oxberry MBChB BSc (Hons) FRCP PhD
Director of Fundraising and Marketing. Mr Ryan Judson BA(Hons)
Associate Director of Retail
Mr Paul Freethy
27
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
Auditor
Azets Audit Services Limited 12 King Street Leeds LS1 2HL
Principal Bankers Lloyds TSB Bank plc 1 Westgate Huddersfield HD1 2DN
Investment Managers Rathbones Quayside House Canal Wharf Leeds LS11 5PU
28
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Trustees' Annual Report for the year ended 31 March 2026 (continued)
Auditors
Azets Audit Services Limited were appointed as auditor to the company and are deemed to be reappointed under section 487(2) of the Companies Act 2006.
Disclosure of information to the auditors
We, the Trustees, being directors of the company, who held office at the date of approval of these financial statements as set out above each confirm, so far as we are aware, that:
-
there is no relevant audit information of which the company’s auditors are unaware; and
-
we have taken all the steps that we ought to have taken as directors in order to make ourselves aware of any relevant audit information and to establish that the company’s auditors are aware of that information.
In approving the Trustees' Annual Report, we also approve the Strategic Report included therein, in our capacity as company directors.
On behalf of the board
Miss L A Chapman Chair of Trustees
24 September 2026
………………………….
29
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Statement of Trustees’ Responsibilities in Respect of the Trustees’ Report and the Financial Statements
The Trustees (who are also directors of Kirkwood Hospice for the purposes of company law) are responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including FRS 102 the Financial Reporting Standard applicable in the UK and Republic of Ireland. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the charitable group for that period.
In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP (FRS 102);
-
make judgments and estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company and group will continue in business.
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
In so far as the Trustees are aware:
-
there is no relevant audit information of which the charitable company's auditor is unaware; and
-
• the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the charitable company’s auditor is aware of that information.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
30
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Independent Auditor’s Report to the Members of Kirkwood Hospice
Opinion
We have audited the financial statements of Kirkwood Hospice (the “parent charity”) and its subsidiary (the “group”) for the year ended 31 March 2026 which comprise the consolidated statement of financial activities, the company and consolidated balance sheets, the consolidated cash flow statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
-
give a true and fair view of the state of the group’s and the parent charitable company’s affairs as at 31 March 2026 and of its income and expenditure for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the Trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on both the group’s and the parent charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.
Other information
The Trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.
31
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Independent Auditor’s Report to the Members of Kirkwood Hospice (continued)
Other information (continued)
If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the Trustees’ report (incorporating the strategic report and the directors’ report) for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the Trustees’ report (incorporating the strategic report and the directors’ report) has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
-
adequate accounting records have not been kept or returns adequate for our audit have not been received from branches not visited by us;
-
the financial statements are not in agreement with the accounting records and returns;
-
certain disclosures of Trustees’ remuneration specified by law are not made; or
-
we have not obtained all the information and explanations necessary for the purposes of our audit.
Responsibilities of the Trustees for the financial statements
As explained more fully in the Trustees’ responsibilities statement, the Trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Trustees are responsible for assessing the group’s and the parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.
32
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Independent Auditor’s Report to the Members of Kirkwood Hospice (continued)
Our responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilites. This description forms part of our auditor’s report.
Extent to which the audit was considered capable of identifying irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.
We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.
In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:
-
Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud;
-
Reviewing minutes of meetings of those charged with governance;
-
Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the charity through enquiry and inspection;
-
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
-
Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias; and
-
Performing audit work over the timing and recognition of revenue and in particular whether it has been recorded in the correct accounting period.
33
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Independent Auditor’s Report to the Members of Kirkwood Hospice (continued)
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Use of our report
This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Jessica Lawrence (Senior Statutory Auditor) For and on behalf of Azets Audit Services Limited
24 September 2026 Date: ……………………
Chartered Accountants Statutory Auditor
12 King Street Leeds LS1 2HL
34
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Consolidated Statement of Financial Activities (incorporating an income and expenditure account) for the year ended 31 March 2026
| Note Income and endowments from: Donatons and legacies 2 Charitable actvites 3 Other trading actvites 4 Income from investments 5 Total income Expenditure on: Raising funds 6 Charitable actvites 6 Total expenditure Net gains/(losses) on investments Net income/(expenditure) Transfers between funds 23 Net movement between funds Reconciliaton of funds: Total funds brought forward 23 Total funds carried forward |
2026 2026 2026 2026 2026 2025 Unrestricted Funds – General £ Designated Fixed Asset Fund £ Restricted Funds £ Endowment Fund £ Total Funds £ Total Funds £ 3,625,816 - 8,567 - 3,634,383 2,314,915 3,882,020 - 609,721 - 4,491,741 3,255,222 5,527,247 - - - 5,527,247 5,209,048 181,860 - - - 181,860 124,843 |
|---|---|
| 13,216,943 - 618,288 - 13,835,231 10,904,028 |
|
| (4,495,622) - - - (4,495,622) (4,254,326) (6,523,350) (422,542) (20,788) - (6,966,680) (7,296,568) |
|
| (11,018,972) (422,542) (20,788) - (11,462,302) (11,550,894) |
|
| 201,926 - - (478) 201,448 142,794 |
|
| 2,399,897 (422,542) 597,500 (478) 2,574,377 (504,072) |
|
| (69,488) 679,209 (609,721) - - - 2,330,409 256,667 (12,221) (478) 2,574,377 (504,072) |
|
| 5,168,125 4,016,518 71,603 6,593 9,262,839 9,766,911 |
|
| 7,498,534 4,273,185 59,382 6,115 11,837,216 9,262,839 |
The results for the year all relate to continuing operations.
A detailed statement of financial activities for the comparative year is shown in note 29 to the financial statements.
The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
The statement of financial activities includes all gains and losses recognised in the year.
35
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Balance Sheet as at 31 March 2026
| Fixed assets Tangible assets 14 Investments 15 Current assets Stock 16 Debtors 17 Cash on deposit, at bank and in hand Creditors: amounts falling due within one year 18 Net current assets Total assets less current liabilites Creditors: amounts due afer more than one year 19 Net assets Charity Funds Endowment funds Permanent endowment 23 Restricted funds 23 Unrestricted funds 23 Total charity funds |
Group Charity 2026 2025 2026 2025 £ £ £ £ 4,273,185 4,016,518 4,273,185 4,016,518 5,173,394 3,539,715 5,173,494 3,539,815 |
|---|---|
| 9,446,579 7,556,233 9,446,679 7,556,333 42,245 55,363 7,801 10,542 2,666,428 1,001,863 2,708,315 1,025,181 923,091 1,729,606 828,723 1,646,691 |
|
| 3,631,764 2,786,832 3,544,839 2,682,414 (1,241,127) (1,070,123) (1,217,137) (1,038,743) |
|
| 2,390,637 1,716,709 2,327,702 1,643,671 |
|
| 11,837,216 9,272,942 11,774,381 9,200,004 - (10,103) - - |
|
| 11,837,216 9,262,839 11,774,381 9,200,004 |
|
| 6,115 6,593 6,115 6,593 59,382 71,603 59,382 71,603 11,771,719 9,184,643 11,708,884 9,121,808 |
|
| 11,837,216 9,262,839 11,774,381 9,200,004 |
24 September 2026 These financial statements were approved by the board of Trustees on ………………………….. and were authorised for issue and signed on its behalf by:
Miss L A Chapman
Chair of Trustees
Company registration number: 01645888
The notes on pages 38-56 form part of the financial statements
36
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Consolidated Cash Flow Statement for the year ended 31 March 2026
| 2026 2025 £ £ £ £ Net cash fow used by operatng actvites 1,131,158 (524,960) Cash fows from investng actvites: Purchase of tangible fxed assets (679,209) (159,373) Payments to acquire investments (3,390,612) (3,063,683) Proceeds from the sale of investments 1,958,381 4,600,442 Interest received 9,115 5,722 Interest Paid (365) 505 Dividends received 172,745 2,375 119,121 2,530 Proceeds on disposal of assets Net cash fow from investng actvites (1,927,570) 1,505,264 Cash fow from fnancing actvites Payment of bank loan (10,103) (12,401) Net cash fow from fnancing actvites (10,103) (12,401) Change in cash and cash equivalents in the year (806,515) 967,903 Cash and cash equivalents at the beginning of the year 1,729,606 761,703 Cash and cash equivalents at the end of the year 923,091 1,729,606 Reconciliaton of net income to net cash fow from operatng actvites 2026 2025 £ £ Net income/(expenditure) for the year 2,574,377 (504,072) Depreciaton charge 422,542 309,309 Unrealised loss/(gain) on investments (201,448) (142,794) Dividends and interest (172,745) (119,121) Interest receivable (9,115) (5,722) Interest payable 365 (505) Proft on sale of fxed assets (2,375) (2,530) (Increase)/decrease in stock 13,118 (1,512) (Increase)/decrease in debtors (1,664,565) (241,645) Increase/(decrease) in creditors 171,004 183,632 Net cash outlow from operatng actvites 1,131,158 (524,960) |
2026 2025 £ £ £ £ Net cash fow used by operatng actvites 1,131,158 (524,960) Cash fows from investng actvites: Purchase of tangible fxed assets (679,209) (159,373) Payments to acquire investments (3,390,612) (3,063,683) Proceeds from the sale of investments 1,958,381 4,600,442 Interest received 9,115 5,722 Interest Paid (365) 505 Dividends received 172,745 2,375 119,121 2,530 Proceeds on disposal of assets Net cash fow from investng actvites (1,927,570) 1,505,264 Cash fow from fnancing actvites Payment of bank loan (10,103) (12,401) Net cash fow from fnancing actvites (10,103) (12,401) Change in cash and cash equivalents in the year (806,515) 967,903 Cash and cash equivalents at the beginning of the year 1,729,606 761,703 Cash and cash equivalents at the end of the year 923,091 1,729,606 Reconciliaton of net income to net cash fow from operatng actvites 2026 2025 £ £ Net income/(expenditure) for the year 2,574,377 (504,072) Depreciaton charge 422,542 309,309 Unrealised loss/(gain) on investments (201,448) (142,794) Dividends and interest (172,745) (119,121) Interest receivable (9,115) (5,722) Interest payable 365 (505) Proft on sale of fxed assets (2,375) (2,530) (Increase)/decrease in stock 13,118 (1,512) (Increase)/decrease in debtors (1,664,565) (241,645) Increase/(decrease) in creditors 171,004 183,632 Net cash outlow from operatng actvites 1,131,158 (524,960) |
2026 2025 £ £ £ £ Net cash fow used by operatng actvites 1,131,158 (524,960) Cash fows from investng actvites: Purchase of tangible fxed assets (679,209) (159,373) Payments to acquire investments (3,390,612) (3,063,683) Proceeds from the sale of investments 1,958,381 4,600,442 Interest received 9,115 5,722 Interest Paid (365) 505 Dividends received 172,745 2,375 119,121 2,530 Proceeds on disposal of assets Net cash fow from investng actvites (1,927,570) 1,505,264 Cash fow from fnancing actvites Payment of bank loan (10,103) (12,401) Net cash fow from fnancing actvites (10,103) (12,401) Change in cash and cash equivalents in the year (806,515) 967,903 Cash and cash equivalents at the beginning of the year 1,729,606 761,703 Cash and cash equivalents at the end of the year 923,091 1,729,606 Reconciliaton of net income to net cash fow from operatng actvites 2026 2025 £ £ Net income/(expenditure) for the year 2,574,377 (504,072) Depreciaton charge 422,542 309,309 Unrealised loss/(gain) on investments (201,448) (142,794) Dividends and interest (172,745) (119,121) Interest receivable (9,115) (5,722) Interest payable 365 (505) Proft on sale of fxed assets (2,375) (2,530) (Increase)/decrease in stock 13,118 (1,512) (Increase)/decrease in debtors (1,664,565) (241,645) Increase/(decrease) in creditors 171,004 183,632 Net cash outlow from operatng actvites 1,131,158 (524,960) |
2026 2025 £ £ £ £ Net cash fow used by operatng actvites 1,131,158 (524,960) Cash fows from investng actvites: Purchase of tangible fxed assets (679,209) (159,373) Payments to acquire investments (3,390,612) (3,063,683) Proceeds from the sale of investments 1,958,381 4,600,442 Interest received 9,115 5,722 Interest Paid (365) 505 Dividends received 172,745 2,375 119,121 2,530 Proceeds on disposal of assets Net cash fow from investng actvites (1,927,570) 1,505,264 Cash fow from fnancing actvites Payment of bank loan (10,103) (12,401) Net cash fow from fnancing actvites (10,103) (12,401) Change in cash and cash equivalents in the year (806,515) 967,903 Cash and cash equivalents at the beginning of the year 1,729,606 761,703 Cash and cash equivalents at the end of the year 923,091 1,729,606 Reconciliaton of net income to net cash fow from operatng actvites 2026 2025 £ £ Net income/(expenditure) for the year 2,574,377 (504,072) Depreciaton charge 422,542 309,309 Unrealised loss/(gain) on investments (201,448) (142,794) Dividends and interest (172,745) (119,121) Interest receivable (9,115) (5,722) Interest payable 365 (505) Proft on sale of fxed assets (2,375) (2,530) (Increase)/decrease in stock 13,118 (1,512) (Increase)/decrease in debtors (1,664,565) (241,645) Increase/(decrease) in creditors 171,004 183,632 Net cash outlow from operatng actvites 1,131,158 (524,960) |
2026 2025 £ £ £ £ Net cash fow used by operatng actvites 1,131,158 (524,960) Cash fows from investng actvites: Purchase of tangible fxed assets (679,209) (159,373) Payments to acquire investments (3,390,612) (3,063,683) Proceeds from the sale of investments 1,958,381 4,600,442 Interest received 9,115 5,722 Interest Paid (365) 505 Dividends received 172,745 2,375 119,121 2,530 Proceeds on disposal of assets Net cash fow from investng actvites (1,927,570) 1,505,264 Cash fow from fnancing actvites Payment of bank loan (10,103) (12,401) Net cash fow from fnancing actvites (10,103) (12,401) Change in cash and cash equivalents in the year (806,515) 967,903 Cash and cash equivalents at the beginning of the year 1,729,606 761,703 Cash and cash equivalents at the end of the year 923,091 1,729,606 Reconciliaton of net income to net cash fow from operatng actvites 2026 2025 £ £ Net income/(expenditure) for the year 2,574,377 (504,072) Depreciaton charge 422,542 309,309 Unrealised loss/(gain) on investments (201,448) (142,794) Dividends and interest (172,745) (119,121) Interest receivable (9,115) (5,722) Interest payable 365 (505) Proft on sale of fxed assets (2,375) (2,530) (Increase)/decrease in stock 13,118 (1,512) (Increase)/decrease in debtors (1,664,565) (241,645) Increase/(decrease) in creditors 171,004 183,632 Net cash outlow from operatng actvites 1,131,158 (524,960) |
|---|---|---|---|---|
| (12,401) 2026 £ 2,574,377 422,542 (201,448) (172,745) (9,115) 365 (2,375) 13,118 (1,664,565) 171,004 |
||||
(10,103) (806,515) 1,729,606 |
(12,401) 967,903 761,703 |
|||
| 923,091 | 1,729,606 | |||
2025 £ (504,072) 309,309 (142,794) (119,121) (5,722) (505) (2,530) (1,512) (241,645) 183,632 |
||||
| 1,131,158 | (524,960) |
37
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements for the Year Ended 31 March 2026
1 Accounting Policies
The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:
Charity Information
Kirkwood Hospice is a registered charity and a company limited by guarantee, the liability of the members is limited to one pound, and a charity registered in England and Wales. The registered office is 21 Albany Road, Dalton, Huddersfield, HD5 9UY.
Accounting Convention
The financial statements have been prepared on a going concern basis in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019) (Charities SORP(FRS102)), the Financial Reporting Standard applicable in the UK and Ireland (FRS 102), the Companies Act 2006 and the Charities Act 2011.
Kirkwood Hospice meets the definition of a public benefit entity under FRS 102.
Assets and liabilities are initially recognised at cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.
The principal accounting policies adopted in the preparation of the financial statements have remained unchanged from previous years and are set out below.
Going Concern
The charitable group meets its daily working capital requirements through its bank account which had funds of £923k at 31 March 2026. The charity relies heavily upon funding from voluntary donations, legacies and grants, which all contain elements of uncertainty. Given the charitable company’s favourable fundraising record and the level of free reserves available at the year end, the Trustees consider that the charitable company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.
Group financial statements
The financial statements consolidate the results of the charity and its wholly owned subsidiary Kirkwood Hospice Enterprises Limited on a line-by-line basis. The summarised profit and loss account for the subsidiary is shown in note 15. A separate Statement of Financial Activities, including the income and expenditure account, for the charity itself is not presented because the charity has taken advantage of the exemptions offered by the Companies Act 2006 and the SORP 2019. The gross income of the charity was £13,835,231 (2025: £10,904,028) and the net expenditure was £11,462,302 ( 2025: £11,550,894 ) (before gains/losses on investments in each year).
Fund accounting
Unrestricted funds are available for use at the discretion of the Trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
38
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
1 Accounting Policies (continued)
Endowment funds represent those assets which must be held permanently by the charity, principally fixed asset investments. Income arising on the endowment funds can be used in accordance with the objects of the charity and is included as unrestricted income. Any capital gains or losses arising on the investments form part of the fund. Investment management charges and legal advice relating to the fund are charged against the fund.
Income Recognition
All income is included in the Statement of Financial Activities (SoFA) when the charity is legally entitled to the income after any performance conditions have been met, the amount can be measured reliably, and it is probable that the income will be received.
For donations to be recognised the charity will have been notified of the amounts and the settlement date in writing. If there are conditions attached to the donation and this requires a level of performance before entitlement can be obtained, then income is deferred until those conditions are fully met or the fulfilment of those conditions is within the control of the charity, and it is probable that they will be fulfilled.
Donated facilities and donated professional services are recognised in income at their fair value when their economic benefit is probable, it can be measured reliably, and the charity has control over the item. Fair value is determined on the basis of the value of the gift to the charity. For example, the amount the charity would be willing to pay in the open market for such facilities and services. A corresponding amount is recognised in expenditure.
No amount is included in the financial statements for volunteer time in line with the SORP (FRS 102). Further detail is given in the Trustees' Annual Report.
Where practicable, gifts in kind donated for distribution to the beneficiaries of the charity are included in stock and donations in the financial statements upon receipt. If it is impracticable to assess the fair value at receipt or if the costs to undertake such a valuation outweigh any benefits, then the fair value is recognised as a component of donations when it is distributed, and an equivalent amount recognised as charitable expenditure.
The SORP (FRS102) requires gifts in kind donated for resale to be included at fair value, being the expected proceeds from sale less the expected costs of sale. Where estimating the fair value is practicable upon receipt it is recognised in stock and 'Income from other trading activities'. Upon sale, the value of the stock is charged against 'Income from other trading activities' and the proceeds are recognised as 'Income from other trading activities'. Where it is impracticable to fair value the items due to the volume of low value items they are not recognised in the financial statements until they are sold, and the income recognised within 'Income from other trading activities'. The Trustees believe that it is impractical to recognise the goods at fair value upon receipt and have therefore continued to include the income when the goods are sold.
Fixed asset gifts in kind are recognised when receivable and are included at fair value. They are not deferred over the life of the asset.
Legacy income is recognised when the charity is entitled to the income. Under SORP (FRS 102) it’s the earlier of the charity being notified of an impending distribution or the legacy being received or if, before receipt, there is sufficient evidence that it is probable that the legacy will be received and the value of the income can be measured with sufficient reliability. When the charity has received notification of a legacy, but it is not possible to measure the amount expected the legacy is treated as a contingent asset and disclosed.
Income from trading activities includes income earned from fundraising events and trading activities to raise funds for the charity. Income is received in exchange for supplying goods and services in order to raise funds and is recognised when entitlement has occurred.
39
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
1 Accounting Policies (continued)
Income recognition (continued)
The charity receives grants in respect of its charitable activities. Income from grants is recognised at fair value when the charity has entitlement after any performance conditions have been met, it is probable that the income will be received and the amount can be measured reliably. If entitlement is not met then these amounts are deferred.
Investment income is earned through holding assets for investment purposes such as shares and property. It includes dividends and interest when the amount can be measured reliably.
Interest income is recognised using the effective interest method and dividend income is recognised as the charity's right to receive payment is established.
Expenditure and irrecoverable VAT
All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Expenditure is recognised where there is a legal or constructive obligation to make payments to third parties, it is probable that the settlement will be required and the amount of the obligation can be measured reliably. It is categorised under the following headings:
-
Costs of raising funds includes the cost of commercial trading and their associated support costs.
-
Expenditure on charitable activities includes the cost of running and maintaining the hospice along with other costs undertaken to further the purpose of the charity and their associated support costs; and
-
Other expenditure represents those items not falling into the categories above.
Irrecoverable VAT is charged as an expense against the activity for which expenditure arose.
Support costs
Support costs are those that assist the work of the charity but do not directly represent charitable activities and include office costs, governance costs, and administrative payroll costs. They are incurred directly in support of expenditure on the objects of the charity. Where support costs cannot be directly attributed to particular headings, they have been allocated to the cost of raising funds and the expenditure on charitable activities on a basis consistent with use of the resources. Premises overheads and other overheads have been allocated pro rata to staff cost basis.
Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of promoting the charitable activities of the charity. The analysis of these costs is included in note 6.
Pensions
Employees who have previously worked for the NHS are entitled to continue to contribute to the NHS Pension Scheme subject to certain conditions. The NHS Scheme is an unfunded final salary scheme operated by the National Health Service. The contributions are calculated so as to spread the cost of pensions over employees’ working lives, whilst they remain in qualifying employment, in such a way that the pension cost is a substantially level percentage of current and future pensionable payroll. The contributions are determined by the Government Actuary on the basis of periodic valuations, and any deficit is underwritten by the Treasury.
The scheme is not designed to be run in a way that would enable employers of eligible employees to identify their share of the underlying scheme assets and liabilities, and the scheme is unfunded. Therefore, the scheme is accounted for as if it were a defined contribution scheme: the amount charged against profits represents the contributions payable to the scheme.
Staff not entitled to join the NHS Scheme are automatically enrolled into a defined contribution scheme, in accordance with current pension legislation. In addition, the defined contribution scheme is offered on the same terms to staff not meeting the criteria for automatic enrolment. The amount charged against profits for the scheme represents the contributions payable to the scheme in respect of the accounting period.
40
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
1 Accounting Policies (continued)
Staff costs
The costs of short-term employee benefits are recognised as a liability and an expense where settlement of obligations does not fall within the same period.
Redundancy costs
Redundancy costs are recognised as an expense when the charity is demonstrably committed to a formal plan to terminate the employment of one or more employees and has no realistic possibility of withdrawal. A provision is recognised when the plan has been communicated to affected employees and the amount of the obligation can be reliably estimated. Redundancy costs include statutory and contractual termination payments, related payroll taxes, and other directly attributable costs.
Investments
Investments (other than investments in subsidiaries) are stated at market value at the balance sheet date.
The investment portfolio, see note 15, is held to generate returns and gains for the group and accordingly is designated as fair value through profit and loss (“FVTPL”). Under this designation the portfolio is revalued at each period end to its fair value, as determined by reference to quoted market prices and values determined by independent fund managers, with any gains or losses going through the statement of financial activity.
Investments in subsidiaries are stated at cost and the Trustees review the carrying value annually for indications of impairment.
Fixed assets and depreciation
Tangible fixed assets costing £1,000 or more are capitalised at cost (or deemed cost). Cost includes costs directly attributable to making the asset capable of operating as intended.
Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:
Freehold land No depreciation provided Freehold buildings 2% Straight line Shop fittings The lower of the life of the lease or 5 years Furniture, furnishings and equipment 20% Straight line Computer equipment 33 ⅓ % Straight line Motor vehicles 20% Straight line
Stocks
Stocks are stated at the lower of cost and net realisable value. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.
Donated items of stock for resale are not included in the financial statements until they are sold. The Trustees consider it impractical to assess the amount of donated stock held as there is no system in place to record these items or value them until they are sold. The value of these goods to the charity is instead recognised when they are sold in the shops.
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Cash at bank and in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity held for working capital.
41
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
1 Accounting Policies (Continued)
Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid.
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in the income and expenditure account.
Creditors, loans and provisions
Creditors, loans and provisions are recognised where the group has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors, loans and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Financial liabilities are only derecognised when, and only when, the group’s obligations are discharged, cancelled or they expire.
Amounts recognised as provisions are best estimates of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation.
Tax
Kirkwood Hospice is a registered charity and as such is a charity within the meaning of schedule 6 of the Finance Act 2010. Accordingly, the Hospice is potentially entitled to tax exemption under part 11 of the Corporation Tax Act 2010 or section 256 of the Taxation of Chargeable Gains Act 1992 in respect of income and gains arising.
The trading subsidiary is liable to corporation tax on its chargeable profits. Current tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantially enacted at the balance sheet date. As all profits arising in the subsidiary were gift aided to the parent charitable company in both the current and prior financial year, no corporation tax has arisen.
Critical accounting estimates and judgements
In the application of the group’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.
Depreciation of tangible assets
Depreciation policies have been set according to management's experience of the useful lives of the assets in each category, something which is reviewed annually.
The charity incurs expenditure on creating tangible fixed assets for use in the charity with costs being incurred over a number of months. The Trustees believe it is possible to segregate these costs into identifiable projects, and as such no depreciation is charged on that project until it is brought into use.
42
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
1 Accounting Policies (Continued)
Legacies
Legacies are recognised as income when probate has been granted, the charity has established its entitlement to the funds and where sufficient information is available to allow it to measure its entitlement.
2 Income from donations and legacies
| Donatons Legacies |
2026 2025 £ £ 710,868 740,825 2,923,515 1,574,090 |
|---|---|
| 3,634,383 2,314,915 |
Included in the above is restricted donations totalling £8,567 (2025: £68,591).
The charity benefits greatly from the involvement and enthusiastic support of its many volunteers, details of these are in the annual report. In accordance with FRS 102 and the charity SORP (FRS 102) the economic contribution of general volunteers is not recognised in the accounts.
3 Income from charitable activities
| Contractual payments Performance related grants |
2026 2025 £ £ 4,491,741 3,207,272 - 47,950 |
|---|---|
| 4,491,741 3,255,222 |
£609,721 of grants from Hospice UK was restricted in the year. All other income from charitable activities is unrestricted in the current and prior year.
4 Income from other trading activities
| 4 Income from other trading actvites |
|
|---|---|
| Fundraising events Lotery Shop income |
2026 2025 £ £ 1,079,394 879,243 813,355 771,405 3,634,498 3,558,400 |
| 5,527,247 5,209,048 |
All income was unrestricted in the current and prior year.
5 Income from investments
| Investment income Interest |
2026 2025 £ £ 172,745 119,121 9,115 5,722 |
|---|---|
| 181,860 124,843 |
All income was unrestricted in the current and prior year.
43
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
| 6 Analysis expenditure For the year ended 31 March 2026 Raising funds Merchandising Lotery Fundraising Investment Charitable actvites In-patent care Kirkwood Integrated Care Service Kirkwood Counselling Team Training and Educaton department Employees & Volunteers Finance, IT & Business Informaton Projects & administraton Total expenditure |
Staf Costs Other Costs Depreciaton Support Costs Total 2026 2026 2026 2026 2026 £ £ £ £ £ 2,009,968 1,241,115 72,380 90 3,323,553 96,458 203,353 - 7,379 307,190 395,612 256,422 - 196,974 849,008 - - - 15,871 15,871 |
|---|---|
| 2,502,038 1,700,890 72,380 220,314 4,495,622 |
|
| 3,032,553 254,168 54,833 1,300,436 4,641,990 1,155,751 15,997 - 482,450 1,654,198 413,762 7,950 - 172,528 594,240 27,231 1,680 - 47,341 76,252 |
|
| 4,629,297 279,795 54,833 2,002,755 6,966,680 |
|
| 241,237 63,184 - (304,421) - 398,992 184,514 - (583,506) - 485,121 426,887 295,329 (1,207,337) - |
|
| 1,125,350 674,585 295,329 (2,095,264) - |
|
| 8,256,685 2,655,270 422,542 127,805 11,462,302 |
All expenditure on raising funds was unrestricted in current and prior year. Included within charitable activities is restricted expenditure totalling £20,788 (2025: £51,978).
| For the year ended 31 March 2025 Raising funds Merchandising Lotery Fundraising Investment Charitable actvites In-patent care Support & therapy centre Community palliatve care Family care team Informaton and educaton Personnel & volunteers Finance & informaton Projects & administraton Total expenditure |
Staf Costs Other Costs Depreciaton Support Costs Total 2025 2025 2025 2025 2025 £ £ £ £ £ 1,941,292 1,120,457 76,936 31,730 3,170,415 81,321 124,334 - 2,446 208,101 446,046 235,868 - 168,896 850,810 - - - 25,000 25,000 |
|---|---|
| 2,468,659 1,480,659 76,936 228,072 4,254,326 |
|
| 3,055,356 197,704 34,557 1,086,162 4,373,779 203,560 10,717 - 68,758 283,035 1,371,100 14,417 - 475,231 1,860,748 252,226 10,998 - 87,712 350,936 280,145 4,611 - 143,314 428,070 |
|
| 5,162,387 238,447 34,557 1,861,177 7,296,568 |
|
| 230,506 81,180 - (311,686) - 284,136 97,406 - (381,542) - 621,645 421,408 197,816 (1,240,869) - |
|
| 1,136,287 599,994 197,816 (1,934,097) - |
|
| 8,767,333 2,319,100 309,309 155,152 11,550,894 |
44
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
7 Allocation of support costs
| Raising funds In-patent care Kirkwood Integrated Care Service Kirkwood Counselling Team Training and educaton |
Personnel & Volunteers 2026 Finance & Informaton 2026 Projects & Administraton 2026 Total 2026 £ £ £ £ 23,967 45,940 95,053 164,960 183,719 352,148 728,633 1,264,500 70,018 134,209 277,693 481,920 25,067 48,047 99,415 172,529 1,650 3,162 6,543 11,355 |
|---|---|
| 304,421 583,506 1,207,337 2,095,264 |
| Raising funds In-patent care Support & Therapy Centre Community Palliatve Care Team Family Care Team Informaton and educaton |
Personnel & Volunteers 2025 Finance & Informaton 2025 Projects & Administraton 2025 Total 2025 £ £ £ £ 24,789 30,345 98,688 153,822 169,800 207,856 675,999 1,053,655 11,313 13,848 45,038 70,199 76,198 93,276 303,357 472,831 14,017 17,159 55,805 86,981 15,569 19,058 61,982 96,609 |
|---|---|
| 311,686 381,542 1,240,869 1,934,097 |
8 Tax charge
The Trust has charitable status, and its investment income and gains are exempt from corporation tax by virtue of the provisions of section 488, Corporation Taxes Act 2010. Furthermore, it is considered that the trading activities of the Trust are carried out as the primary purpose of the charitable company and, accordingly, any element of the operating surplus attributable to such activities is also exempt from corporation tax under the provisions of that section.
9 Investment management costs
| Investment manager fees | 2026 2025 £ £ |
|---|---|
| 15,871 19,672 |
All of the above costs are attributable to unrestricted funds and included within raising funds costs.
45
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Notes to the Financial Statements (continued)
10 Audit fees
| Fees payable to the charity’s auditor for audit Fees payable to the charity’s auditor for other services |
2026 2025 £ £ 18,300 17,400 7,930 6,925 |
|---|---|
| 26,230 24,325 |
Included within the audit fee is £5,700 (2025: £5,400) for the audit of the subsidiary.
11 Net income/(expenditure) for the year
Net income/(expenditure) is stated after charging/(crediting):
| 2026 | 2025 | |
|---|---|---|
| £ | £ | |
| Depreciaton of tangible fxed assets | 422,542 | 309,309 |
| Operatng lease rentals | 326,175 | 348,083 |
| Trustees indemnity insurance | 1,605 | 1,605 |
| Net losses/(gains) on fair value movement of investments | (201,448) | 599,728 |
12 Trustees’ and key management personnel remuneration and expenses
The Trustees neither received nor waived any remuneration during the year (2025: £Nil).
The Trustees did not have any expenses reimbursed during the year (2025: £Nil).
The total amount of employee benefits received by key management personnel is £656,172 (2025: £546,793). The charity considers its key management personnel comprises the Chief Executive, the Director of Finance and Resources, the Director of Clinical Services, the Medical Director, the Director of Fundraising & Marketing and the Associate Director of Retail.
Staff costs and employee benefits
The average monthly number of employees and the full time equivalent (FTE) during the year was as follows:
| Nursing & medical Educaton Catering & domestc Administraton Fundraising & marketng |
2026 2025 Average FTE Average FTE 99 71 120 74 - - 4 3 19 13 22 16 38 27 39 30 113 69 115 75 |
|---|---|
| 269 180 300 198 |
46
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice Notes to the Financial Statements (continued)
13 Staff costs and employee benefits (continued)
The aggregate payroll costs of these persons were as follows:
| Wages and salaries Social security costs Pension costs Consultancy and temporary staf fees |
2026 2025 £ £ 6,559,668 7,249,149 789,656 632,206 498,762 520,816 408,599 365,162 |
|---|---|
| 8,256,685 8,767,333 |
Redundancy costs in the year totalled £nil (2025 - £223,573) including social security costs and pension costs. These amounts are included in the figures above.
The number of higher paid employees is disclosed below.
| £60,001 to £70,000 £70,001 to £80,000 £80,001 to £90,000 £90,001 to £100,000 £100,001 to £110,000 £110,001 to £120,000 £120,001 to £130,000 £130,001 to £140,000 |
2026 2025 No. No. 3 1 2 - - 1 1 - - 2 2 1 1 1 1 - |
|---|---|
| 10 6 |
14 Tangible fixed assets
| CHARITY AND GROUP Cost At 1 April 2025 Additons Disposals At 31 March 2026 Depreciaton At 1 April 2025 Charge for year On disposals At 31 March 2026 Net book value At 31 March 2026 At 31 March 2025 |
Freehold land and buildings Furniture and ftngs Total £ £ £ 5,650,446 2,955,015 8,605,461 - 679,209 679,209 - (10,795) (10,795) |
|---|---|
| 5,650,446 3,623,429 9,273,875 |
|
| 2,008,225 2,580,718 4,588,943 112,593 309,949 422,542 - (10,795) (10,795) |
|
| 2,120,818 2,879,872 5,000,690 |
|
| 3,529,628 743,557 4,273,185 |
|
| 3,642,221 374,297 4,016,518 |
The cost of freehold land and buildings includes £21,000 (2025: £21,000) of land which is not depreciated.
47
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
15 Fixed asset investments
| GROUP | Unrestricted | Unrestricted | Endowment funds | Total | Total |
|---|---|---|---|---|---|
| Investments | 2026 | 2025 | |||
| £ | £ | £ | £ | ||
| Opening Balance | 3,533,122 | 6,593 | 3,539,715 | 4,933,680 | |
| Additons | 3,390,612 | - | 3,390,612 | 3,063,683 | |
| Disposals | (1,958,381) | - | (1,958,381) | (4,600,442) | |
| Realised and unrealised | |||||
| gains/(losses) | 201,926 | (478) | 201,448 | 142,794 | |
| 5,167,279 | 6,115 | 5,173,394 | 3,539,715 | ||
| CHARITY | Unrestricted | Endowment | Equity investment |
Total | Total |
| Investments | funds | in subsidiary | 2026 | 2025 | |
| undertaking | |||||
| £ | £ | £ | £ | £ | |
| Opening Balance | 3,533,122 | 6,593 | 100 | 3,539,815 | 4,933,780 |
| Additons | 3,390,612 | - | - | 3,390,612 | 3,063,683 |
| Disposals | (1,958,381) | - |
- | (1,958,381) | (4,600,442) |
| Revaluaton | 201,926 | (478) | - | 201,448 | 142,794 |
| 5,167,279 | 6,115 | 100 | 5,173,494 | 3,539,815 |
The fair value of investments is determined by reference to the quoted price for identical assets in an active market at the balance sheet date.
The historical cost of financial assets measured at fair value through income and expenditure for both the group and charity is £4,569,333 (2025: £3,091,214).
Investments in group undertakings are measured at cost less impairment on the basis that they represent shares in entities that are not publicly traded and the fair value cannot otherwise be measured reliably.
The charity’s equity investment in subsidiary undertaking is a 100% holding in the ordinary share capital of Kirkwood Hospice Enterprises Limited, a company incorporated in England & Wales (company number 7368034), with its registered office at the same address as its parent. The charity holds 100 shares of £1 each, these are only shares allotted, called up and fully paid.
It pays all of its profits to the charity under the gift aid scheme. Kirkwood Hospice Enterprises Limited operates all commercial trading activity as fundraising in support of the charity. The results and aggregate amount of capital and reserves are disclosed below:
48
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
15 Fixed asset investments (continued)
| 2026 | 2025 | |
|---|---|---|
| £ | £ | |
| Turnover Cost of sales and administraton costs |
277,805 | 265,604 |
| (271,654) | (276,722) | |
| Other operatngincome | - | - |
| (Loss)/proft before tax | 6,151 | (11,118) |
| Tax on(loss)/proft | - | - |
| (Loss)/proft afer tax | 6,151 | (11,118) |
| Amountgif aided to charity | (6,151) | - |
| Retained in subsidiary | - | - |
| The assets and liabilites of the subsidiary were: | ||
| Current assets | 133,510 | 133,985 |
| Current liabilites | (70,575) | (60,948) |
| Creditors: amounts falling due afer more than one year | - | (10,102) |
| Total net assets | 62,935 | 62,935 |
| Aggregate share capital and reserves | 62,935 | 62,935 |
16 Stock
| 16 Stock | |
|---|---|
| Catering & housekeeping Medical supplies Shop and fundraising goods |
Group Charity 2026 2025 2026 2025 £ £ £ £ - 4,114 - 4,114 7,801 6,428 7,801 6,428 34,444 44,821 - - |
| 42,245 55,363 7,801 10,542 |
17 Debtors
| Trade debtors Other taxes and social security Amounts owed by group undertakings Prepayments and accrued income Other Debtors Legacies notfed in advance |
Group Charity 2026 2025 2026 2025 £ £ £ £ 8,870 22,807 8,824 22,807 40,570 12,278 35,918 6,028 - - 46,585 29,698 729,137 286,265 729,137 286,265 1,125 2,934 1,125 2,834 1,886,726 677,549 1,886,726 677,549 |
|---|---|
| 2,666,428 1,001,833 2,708,315 1,025,181 |
49
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
18 Creditors: amounts falling due within one year
| Trade creditors Other taxes and social security costs Accruals Deferred income – note 21 Bank loan Other creditors |
Group Charity 2026 2025 2026 2025 £ £ £ £ 674,892 313,136 666,556 298,785 162,893 141,832 162,893 141,832 223,655 433,465 216,855 426,465 77,871 64,901 77,871 64,901 8,854 10,000 - - 92,962 106,789 92,962 106,760 |
|---|---|
| 1,241,127 1,070,123 1,217,137 1,038,743 |
19 Creditors: amounts falling after more than one year
| Bank loan | Group Charity 2026 2025 2026 2025 £ £ £ £ - 10,103 - - |
|---|---|
| - 10,103 - - |
The bank loan was taken out in July 2022 and will be repaid by monthly instalments over a term of 6 years. The amount repayable in instalments which falls due after more than 5 years from the balance sheet date is £nil (2024: £nil). Interest at 2.5% is due on the amount outstanding.
20 Loans
| 20 Loans | |
|---|---|
| Bank loans: Payable within one year Payable afer one year |
Group Charity 2026 2025 2026 2025 £ £ £ £ 8,854 10,000 - - - 22,504 - - |
| 8,854 32,504 |
21 Deferred income – Group and Charity
| Cost At 1 April 2025 Deferred in the year Amounts release to income At 31 March 2026 |
Total 2026 Total 2025 £ £ 64,901 100,543 77,871 2,956,549 (64,901) (2,992,191) |
|---|---|
| 77,871 64,901 |
Income has been deferred which has been received in advance for future lottery draws of £65,430 (2025: £63,071) and for funding relating to future periods of £12,440 (2025: £1,830).
50
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
22 Leases
Total future minimum lease payments under non-cancellable operating leases are as follows:
| Less than one year Between one year and fve years Later than fve years |
Group Charity 2026 2025 2026 2025 £ £ £ £ 231,032 318,692 231,032 312,859 134,613 325,998 134,613 325,998 - - - - |
|---|---|
| 365,645 644,690 365,645 638,857 |
23 Statement of funds
| For the year ended 31 March 2026 GROUP Unrestricted funds General funds Designated funds Fixed asset fund Hospice UK Capital Programme Total designated funds Total unrestricted funds CHARITY Unrestricted funds General funds Designated funds Fixed asset fund Hospice UK Capital Programme Total designated funds Total unrestricted funds |
As At 1 April 2025 Income Expenditure Gain on investme nt Transfers As at 31 March 2026 £ £ £ £ £ £ 5,168,125 13,216,943 (11,018,972) 201,926 (69,488) 7,498,534 4,016,518 - (306,374) - 69,488 3,779,632 - - (116,168) - 609,721 493,553 |
|
|---|---|---|
| 4,016,518 - (422,542) - 679,209 4,273,185 |
||
| 9,184,643 13,216,943 (11,441,514) 201,926 609,721 11,771,719 |
||
| 5,105,290 12,945,289 (10,747,318) 201,926 (69,488) 7,435,699 4,016,518 - (306,374) - 69,488 3,779,632 - - (116,168) - 609,721 493,553 4,016,518 - (422,542) - 679,209 4,273,185 9,121,808 12,945,289 (11,169,860) 201,926 609,72111,708,884 |
||
| GROUP AND CHARITY Restricted Funds Hospice UK Capital Programme Fixed Asset Fund Capital Works Riser Recliner Chairs Tilt Wheelchair Rota-wash Falls Beds Cuddle Bed Other Endowment |
- 609,721 - - (609,721) - 1,023.47 - (1,023.47) - - - 45,162 - - - - 45,162 13,377 - (13,377) - - - 4,457 - - - - 4,457 - 1,426 (1,426) - - - - 4,522 (4,522) - - - 6,009 - - - - 6,009 1,575 2,619 (440) - 3,754 |
|
| 71,603 618,288 (20,788) - - 59,382 |
||
| 6,593 - - (478) - 6,115 |
||
| 78,196 618,288 (20,788) (478) (609,721) 65,497 |
51
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
23 Statement of funds (continued)
| For the year ended 31 March 2025 GROUP Unrestricted funds General funds Designated funds Fixed asset fund Total designated funds Total unrestricted funds CHARITY Unrestricted funds General funds Designated funds Fixed asset fund Total designated funds Total unrestricted funds GROUP AND CHARITY Restricted Funds Fixed Asset Fund Capital Works The Kirkwood Chorus Support Life Delivery Clinical Educator Rise Recliner Chairs Wheelchair Gardening Cuddle Bed Batley & Spen – Care Co Other Endowment |
For the year ended 31 March 2025 GROUP Unrestricted funds General funds Designated funds Fixed asset fund Total designated funds Total unrestricted funds CHARITY Unrestricted funds General funds Designated funds Fixed asset fund Total designated funds Total unrestricted funds GROUP AND CHARITY Restricted Funds Fixed Asset Fund Capital Works The Kirkwood Chorus Support Life Delivery Clinical Educator Rise Recliner Chairs Wheelchair Gardening Cuddle Bed Batley & Spen – Care Co Other Endowment |
As At 1 April 2024 As restated £ 5,532,125 4,166,454 |
Income £ 10,835,437 - |
Expenditure £ (11,189,607) (309,309) |
Gain on investment Transfers As at 31 March 2025 £ £ £ 143,443 (153,273) 5,168,125 - 159,373 4,016,518 |
|---|---|---|---|---|---|
| 4,166,454 | - |
(309,309) | - 159,373 4,016,518 |
||
| 9,698,579 | 10,835,437 | (11,498,916) | 143,443 6,100 9,184,643 |
||
| 5,458,080 4,166,454 |
10,569,833 - |
(10,912,793) (309,309) |
143,443 (153,273) 5,105,290 - 159,373 4,016,518 |
||
| 4,166,454 | - | (309,309) | - 159,373 4,016,518 |
||
| 9,624,534 | 10,569,833 | (11,222,102) | 143,443 6,100 9,121,808 |
||
| 1,023 45,162 - - - - 4,457 - 6,009 - 4,439 |
- - 1,200 25,000 10,000 13,377 - 5,250 - 7,000 6,764 |
- - (1,200) (25,000) (10,000) - - (5,250) - (7,000) (3,528) |
- - 1,023 - - 45,162 - - - - - - - - - - - 13,377 - - 4,457 - - - - - 6,009 - - - - (6,100) 1,575 |
||
| 61,090 | 68,591 | (51,978) | - (6,100) 71,603 |
||
| 7,242 | - | - | (649) - 6,593 |
||
| 68,332 | 68,591 | (51,978) | (649) (6,100) 78,196 |
Fund descriptions
a) Unrestricted funds
The general funds are available for the use at the discretion of the charity in furtherance of the general objectives as detailed in the Trustees report.
b) Designated funds
Kirkwood Hospice has clear policy and procedures to guide its management of reserves. The policy clarifies in more detail that the charity will hold designated funds to provide for specific future projects that are unlikely to be met by future income alone.
The fixed asset designated fund comprises assets which were purchased to further the aims of the charity and are not considered to be restricted assets.
52
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
23 Statement of funds (continued)
c) Restricted funds
The Hospice UK Capital Programme Fund relates to the funding received from NHS England via Hospice UK to enable hospices to upgrade their equipment, estates and facilities. This funding came with strict restrictions to ensure it was expended on charitable expenditure only, with the aim to release future capital spend. In total £609,721 was received and it was expended on improving The Kirkwood’s commitment to environment sustainability by installing solar panels, LED lighting and two electric support vehicles to replace the petrol vehicles. Investment was made in fire safety, refurbishing our patient treatment rooms, upgrading our telephone system, oxygen manifold system and upgrading our nurse call bell system. Finally, essential tree work and much needed resurfacing to our driveway and onsite parking. The Kirkwood is very grateful for this funding which has been invested wisely to release future large scale capital costs for the next five years. The fund was fully expended and released to unrestricted funds at the end of the accounting period.
The restricted fixed asset fund includes restricted income which has been received for equipment for the charity. The balance of the fund was spent on a Syringe Driver during the accounting period ending 31[st] March 2026.
The capital works fund are grants received for large projects of a capital nature, there was no change to the fund during the accounting period ending 31[st] March 2026.
The Rise Recliner Chairs fund was a new fund in 2024/25 to acquire specialist recliner chairs for patients of The Kirkwood. Donations for the fund were received by the Francis Winham Foundation (£10,000) and from Huddersfield Common Good Trust (£3,377). As of 31 March 2025, a brought forward balance of £13,377 related to this fund, all of which was expended during the financial year ended 31 March 2026.
The wheelchair fund relates to specific funds allocated to acquire wheelchairs to continue to support patients of the hospice. As of 31 March 2025, a brought forward balance of £4,457 related to this fund, in which at the end of the financial year ended 31 March 2026, this remains unchanged.
The rota-fund relates to a specialist floor cleaner funded by Hospice Aid. The donation received was £1,426 all of which was expended on the much-needed floor cleaner during the accounting period ending 31[st] March 2026.
The falls bed fund relates to a specialist bed which support our enabling model of care. An enabling model of care supports our patients to maintain their independence. During the accounting period The Kirkwood received a donation from Towngate to enable The Kirkwood to purchase a falls bed.
The cuddle bed fund receives donations to fund cuddle beds, a recent innovation to provide further comfort and support for palliative care patients. The fund stands at £6,009 from donations received in previous periods, therefore this fund remains unchanged for the year ended 31 March 2026.
Other funds relate to smaller scale projects; this fund had a carried forward balance of £1,575 in 2025/26. During the accounting period total £2,619 was received for contribution towards mattresses, gardening equipment and Christmas gifts for patients. A total of £440 was expended which included £250 for patient Christmas gifts. We would like to acknowledge The Grace Trust, Newlett Homes and Church of St Saviours Ravensthorpe and Thornhill for their generosity in donating the total of £2,619 during 2025/26.
d) Endowment funds
The endowment fund is made up of investments transferred to the charity on condition that the capital should be retained and the income generated either retained or used to support the charities general activities, income generated by the endowment fund is considered to be unrestricted income.
53
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
24 Analysis of net assets between funds
| As at 31 March 2026 GROUP Restricted funds Unrestricted funds - Designated - Unrestricted Endowment CHARITY Restricted funds Unrestricted funds - Designated - Unrestricted Endowment As at 31 March 2025 GROUP Restricted funds Unrestricted funds - Designated - Unrestricted Endowment CHARITY Restricted funds Unrestricted funds - Designated - Unrestricted Endowment |
Tangible fxed assets Investments Cash Other current assets Liabilites Total £ £ £ £ £ £ - - 59,382 - - 59,382 4,273,185 - - - - 4,273,185 - 5,167,279 863,709 2,708,673 (1,241,127) 7,498,534 - 6,115 - - - 6,115 |
|---|---|
| 4,273,185 5,173,394 923,091 2,708,673 (1,241,127) 11,837,216 |
|
| - - 59,382 - - 59,382 4,273,185 - - - - 4,273,185 - 5,167,279 769,341 2,716,216 (1,217,137) 7,435,699 - 6,115 - - - 6,115 |
|
| 4,273,185 5,173,394 828,723 2,716,216 (1,217,137) 11,774,381 |
|
| Tangible fxed assets Investments Cash Other current assets Liabilites Total £ £ £ £ £ £ - - 71,603 - - 71,603 4,016,518 - - - - 4,016,518 - 3,533,122 1,658,003 1,047,123 (1,070,123) 5,168,125 - 6,593 - - - 6,593 |
|
| 4,016,518 3,539,715 1,729,606 1,047,123 (1,070,123) 9,262,839 |
|
| - - 71,603 - - 71,603 4,016,518 - - - - 4,016,518 - 3,533,222 1,575,088 1,035,723 (1,038,743) 5,105,290 - 6,593 - - - 6,593 |
|
| 4,016,518 3,539,815 1,646,691 1,035,723 (1,038,743) 9,200,004 |
25 Pensions and other post-retirement benefits
Employees of the charity are entitled to join either the NHS Pensions Scheme (eligible employees only), or the Kirkwood Hospice Stakeholder Pension Plan.
NHS Pension Scheme
Eligible employees are able to remain in the NHS Pensions Scheme as if they were still in the employment of an employing authority. The NHS Pension Scheme is an unfunded occupational pension scheme backed by the Exchequer, which is open to all NHS employees and employees of approved organisations. The scheme provides pensions, in varying circumstances for employees of participating employers. The scheme receives contributions from employers and employees to defray the costs of pensions and other benefits. The scheme is subject to a full actuarial valuation every four years and an accounting valuation every year. Details of benefits payable, and the basis for valuations under these provisions can be found on the NHS Pensions website at www.nhsbsa.nhs/pensions. The scheme is accounted for as a multi-employer scheme under the Charity SORP (FRS102) and, as no surplus or deficit is able to be identified and allocated to the separate employer, the contributions have been accounted for as a defined contribution scheme and no share of the surplus or deficit included in these financial statements.
54
Docusign Envelope ID: A3AFEA79-581F-81AD-81E7-1D2CF795B836
Kirkwood Hospice
Notes to the Financial Statements (continued)
In the year ended 31 March 2025, the charity made contributions to the NHS Pension Scheme totalling £284,123 (2025: £300,766). Employer contributions were 14.38% and employee contributions were in the range of 5.6% to 13.5% of pensionable pay.
Other Pension Schemes
Other employees are entitled to join the AEGON - Kirkwood Hospice Stakeholder Pension Plan, which is a defined contribution scheme. The contribution rates for this scheme are 7.5% of pensionable pay for the employer and 6% of pensionable pay for the employee. New employees are auto enrolled if eligible into this scheme, the contribution rates being 5% for the employer and 5% for the employee. The employee then has the option to increase their contributions to 6% if they so wish. In the year ending 31 March 2025, the charity paid contributions to the schemes totalling £214,639 (2025: £220,049). The contributions are allocated to unrestricted funds.
26 Contingent asset
At the year end the charity had 35 legacies (2025: 22) confirmed, which the Trustees believe are unable to be measured reliably as the solicitors at present are unable to quantify the value of the proposed estate.
27 Financial commitments
There were no contractual commitments for the acquisition of tangible fixed assets in the current or preceding year.
28 Related party transactions
During the year donations totalling £1,509 (2025: £1,391), excluding the value of donated goods, were received from Trustees, none of these had conditions attached. There were no other related party transactions.
29 Consolidated Statement of Financial Activities (incorporating an income and expenditure account) for the year ended 31 March 2025
| ended 31 March 2025 | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2025 | 2025 | 2025 | 2025 | 2024 | |
| Unrestricted Funds – General £ |
Designated Fixed Asset Fund £ |
Restricted Funds £ |
Endowment Fund £ |
Total Funds £ |
Total Funds £ |
|
| Income and endowments from: | ||||||
| Donatons and legacies | 2,246,324 | - | 68,591 | - |
2,314,915 | 1,657,418 |
| Charitable actvites | 3,255,222 | - | - | - |
3,255,222 | 2,852,614 |
| Other tradingactvites | 5,209,048 | - | - | - |
5,209,048 | 4,777,032 |
| Income from investments | 124,843 | - | - | - |
124,843 | 124,039 |
| 10,835,437 | - | 68,591 | - |
10,904,028 | 9,411,103 | |
| Expenditure on: | ||||||
| RaisingFunds | (4,254,326) | - | - | - |
(4,254,326) | (3,714,306) |
| Charitable actvites | (6,935,281) | (309,309) | (51,978) | - | (7,296,568) | (6,968,243) |
| Total expenditure: | (11,189,607) | (309,309) | (51,978) | - | (11,550,894) | (10,682,549) |
| Netgain on investments | 143,443 | - | - | (649) |
142,794 | 347,641 |
| Net income/ (expenditure) | (210,727) | (309,309) | 16,613 | (649) |
(504,072) | (923,805) |
| Transfers between funds | (153,273) | 159,373 | (6,100) | - | - | - |
| Net movement between funds | (364,000) | (149,936) | 10,513 | (649) |
(504,072) | (923,805) |
| Reconciliaton of funds: | ||||||
| Total funds brought forward | 5,532,125 | 4,166,454 | 61,090 | 7,242 |
9,766,911 | 10,690,716 |
| Total funds carried forward | 5,168,125 | 4,016,518 | 71,603 | 6,593 |
9,262,839 | 9,766,911 |
55